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Abstract 
Decreases in overall well-being and daily functioning result from unpleasant and 
uncomfortable symptoms associated with physical health and mental health disorders.  
Neurofeedback training, rooted in the theory of operant conditioning, presents the 
possibility of increasing brain wave regulation, decreasing symptoms experienced from 
abnormal brain wave activity, and increasing overall well-being and daily functioning.  
The efficacy of neurofeedback for physical and mental health outcomes is unclear, 
contributing to confusion about the treatment and any potential benefits.  In order to 
assess the efficacy of neurofeedback in the alleviation of physical health and mental 
health symptoms, a systematic review and meta-analysis of neurofeedback using a 
random effects model to generate the effect sizes was conducted on 21 studies with 22 
comparisons that used neurofeedback to treat patients.  The results showed that 
neurofeedback can be effective for physical and mental health outcomes, including for 
autism with an effect size of 0.29, tinnitus with an effect size of 0.77, schizophrenia with 
an effect size of 0.76, depression with an effect size of 0.28, insomnia with an effect size 
of 0.52, obesity with an effect size of 0.40, intellectual disability with an effect size of 
0.73, and pain with an effect size of 0.30.  Well-being and daily functioning for those 
with physical and mental health disorders can be improved.  These findings have 
implications for clinical practice to help patients in treatment for physical and mental 
health problems, and also for social change by providing evidence for alternative health 
care options.    
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Chapter 1: Introduction to the Study 
Introduction 
This meta-analysis addressed the overall efficacy of neurofeedback for physical 
health and mental health outcomes.  Physical and mental health are significant to safety 
and peace as much as they are to positive social existence (World Health Organization, 
2018).  Neurofeedback has roots dating back to the 1950s, with evolution in techniques, 
software, and hardware still occurring today, leaving inconsistencies about the details of 
the treatment and its overall efficacy (Thompson & Thompson, 2016).  In psychology 
education, it is important to critically evaluate evidence across a diverse body of research 
on a given topic.  For aspiring educators, it is important to master knowledge to be shared 
through the active construction of that knowledge, making it easily transferred to learners 
through non-passive educational applications (Horn, Kamata, & Midwestern Higher 
Education Compact, 2014).  Thus, in addition to demonstrating mastery of meta-analysis 
research protocols, this systematic review and meta-analysis of the efficacy of 
neurofeedback has pedagogic value for understanding the body of evidence on 
neurofeedback for physical health and mental health outcomes. 
Background 
Pharmacological and non-pharmacological treatment options are available for a 
variety of physical and mental health conditions, and there are numerous reasons why one 
option might be chosen over the other.  For example, Cipriani et al. (2018) cited a lack of 
adequate resources as a reason why pharmacology is used more frequently than other 
psychological interventions for depression.  Dehghani-Arani, Rostami, and Nadali (2013) 
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stated that substance abuse is frequently treated both pharmacologically and behaviorally, 
but even with significant resources being dedicated to improving treatment outcomes, 
seven out of 10 treatment recipients relapse.  Van Doren et al. (2018) indicated that 
pharmacology and psychological intervention are the most effective for the short-term 
treatment of attention deficits, with neurofeedback cited as effective for long term 
treatment of attention deficits with lasting effects beyond the point when neurofeedback 
treatment stops.  According to Cipriani et al. (2018) psychiatric disorders account for 
almost 23% of global disorders, and according to Batson, Merson, and Dzau (2017), 
global health is in need of a challenge to old practices and ways of thinking to encourage 
and embrace change and innovation to save lives and improve health outcomes.  
Neurofeedback offers an innovative approach to physical and mental health, yet it 
remains controversial as to whether or not it is efficacious. 
Abnormal brain behavior is a cited cause for psychological abnormalities and 
functioning, and with some links to abnormal physical health such as pain, epilepsy, and 
so forth (Marzbani, Marateb, & Mansourian, 2016).  Neurofeedback according to 
Alkoby, Abu-Rmileh, Shriki, and Todder (2017) and Marzbani et al. (2016) lacks 
conclusive evidence of its efficacy, but is commonly used to treat attention deficits, 
anxiety, depression, epilepsy, eating disorders, emotional disorders, insomnia, substance 
abuse, substance dependence, other addictions, schizophrenia, stroke, tinnitus, learning 
disabilities, dyslexia, dyscalculia, autism, pain, and so forth.  Reduction or amelioration 
of these physical and mental health disorders and symptoms are likely to improve the 
daily functioning of the individual.  However, Alkoby et al. (2017) and Thibault and Raz 
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(2017) cautioned that simply because neurofeedback is used to treat such a wide range of 
conditions, it does not mean that neurofeedback is effective in treating those conditions or 
symptoms.  Thibault and Raz (2017) reported that placebo is a likely cause of 
neurofeedback success, and Alkoby et al. (2017) reported that many treated with 
neurofeedback do not benefit from the treatment, adding that it is difficult to predict 
which individuals will benefit from treatment and who will not.  To date, no researcher 
has conducted a meta-analysis on the use of neurofeedback for physical and mental 
health outcomes, leaving the efficacy debate to the specific symptom or disorder being 
treated rather than with a larger consideration of how neurofeedback may improve 
physical and mental health.  Adaptive approaches to global health, including mental 
health, could save or improve lives by millions (Batson et al., 2017).  
The value in conducting meta-analytic research for an aspiring educator rests in 
the educator’s need to understand and apply his or her ability to interpret meta-analytic 
research to understand a body of research as well as to teach others to understand a body 
of research to make their instruction increasingly effective (Ouyang & Stanley, 2014; 
Horn, et al., 2014; Blank, 2013).  For example, Horn et al. (2014) reported that in the 
collegiate landscape, mastery learning far exceeds the traditional lecture in student 
success, noting that the traditional lecture method relies on the antiquated ideal that 
students passively learn.  Blank (2013) outlined the transformation of professional 
educator development (educator learning) to student success as a process including active 
engagement in learning activities that require participation, learning and outcome goals, 
and learning about how students learn which translate to educator knowledge and skills 
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influencing educator instruction and student success simultaneously.  Knowledge is 
constructed through learning and learning occurs through knowledge construction, which 
requires an educator to be flexible in acquiring and dispensing knowledge to increase 
both the quality and effectiveness of instruction (Ouyang & Stanley, 2014).  Active 
participation in learning, such as conducting meta-analytic research, presents an 
opportunity for mastery learning which requires demonstrating proof of learning through 
experience, application, and integration (Horn et al., 2014).  Thus, my systematic review 
and meta-analysis of the efficacy of neurofeedback for physical and mental health 
outcomes (a) has pedagogic value as an example of meta-analysis as a tool for 
understanding a body of evidence for mastery learning and future instruction, and (b) 
contributes to current body of knowledge on neurofeedback’s efficacy for physical and 
mental health outcomes.  
Problem Statement  
Neurofeedback, also known as electroencephalograph (EEG) biofeedback, is a 
clinical treatment modality involving the use of operant conditioning to train brain waves.  
Wigton and Krigbaum (2015) described neurofeedback as a process that uses scalp 
sensors, an amplifier, and computer software to train specific brain wave frequencies 
noted from the EEG that are not working in the target range.  Neurofeedback, as a clinical 
treatment modality and in a specific context, can be used in conjunction with most 
clinical treatments such as psychotherapy, psychology, nursing, chiropractic care, 
medical care, and so forth.  According to Cleary (2011), psychological disorders that are 
characterized by specific patterns of brain activity are visible via an EEG.  These 
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abnormal brain waves can then be trained via neurofeedback to help regulate the brain 
waves towards normal, which simultaneously treats the symptoms that are associated 
with psychological disorders (Cleary, 2011).  Symptoms of psychological disorders have 
the potential to be unpleasant and uncomfortable, contributing to an overall decrease in 
physical and mental health (daily functioning). 
As with other clinical treatment modalities, adverse or iatrogenic effects are 
possible with neurofeedback (Hammond & Kirk, 2015).  Specific reasons why 
neurofeedback might present such adverse or iatrogenic effects include an increase in 
unqualified professionals providing treatment, a lack of emphasis on standards of practice 
within the field, providers not seeking competency and continuing education trainings, 
and licensed healthcare providers who choose not to obtain a neurofeedback certification 
(Hammond & Kirk, 2015).  Perhaps the adverse effects result from variability in the 
neurofeedback treatment.  There is a lack of clarity about the efficacy of neurofeedback 
or how strong the evidence for efficacy is across studies with varying designs and quality 
(Alkoby et al., 2017).  In psychology education it is important to consider a body of 
research on a topic and not just single studies of treatment effectiveness, and also to 
assess the contextual factors across studies, such as populations, study design, and 
endpoints that contribute to varying results.  This is important to consumers of research in 
psychology and psychology education.  I undertook this study on the premise that a meta-
analysis of the existing research on neurofeedback could provide new insight into its 
efficacy for physical and mental health outcomes as well as provide an update for the 
field regarding the existing research.   
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As scientists studying the mind and behavior, psychology practitioners and 
teachers use systematic scientific methods to observe, describe, predict, change, teach, 
explain, analyze, or draw conclusions about people and data (King, 2016).  For example, 
in psychology education, it is important that the educator is able to critically evaluate 
evidence across a diverse body of research on a given topic.  Meta-analysis can be an 
important tool for the synthesis of this evidence.  Psychologists examine available 
evidence to make determinations about the strength of data to provide answers to 
questions related to human existence (King, 2016).  Improving physical and mental 
health, as measured by reductions in psychological diagnoses or experienced 
psychological symptomology, or simply by improved feelings of wellness, is of central 
importance to humans, psychologists and teachers included.   
In my search for currently available meta-analyses and systematic reviews of 
neurofeedback and biofeedback, I found six studies:  Tan et al. (2009) focused on 
neurofeedback specifically for epilepsy and seizures, Schoenberg and David (2014) 
bundled neurofeedback and biofeedback without meta-analysis, Luctkar-Flude and Groll 
(2015) focused on neurofeedback for fatigue and cognition, Rogala et al. (2016) focused 
on neurofeedback training, Mirifar, Beckman, and Ehrlenspiel (2017) focused on 
neurofeedback for optimizing athletic performance, and Renton, Tibbles, and Topolovec-
Vranic (2017) focused on neurofeedback for cognitive rehabilitation following a stroke.  
Due to the lack of data on neurofeedback for physical and mental health outcomes, 
opportunities for health and mental health efficiency and improvement might be missed. 
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Purpose 
Neurofeedback is a specialty treatment (or therapy) that has roots dating back to 
the 1950s, with evolution in techniques, software, and hardware still occurring today, 
leaving inconsistencies about the details of the treatment (Thompson & Thompson, 
2016).  For example, neurofeedback treatment approaches like live z-score and low 
resolution electromagnetic tomography (LORETA) neurofeedback are more recent 
advances in treatment approaches, treatment technology, and treatment applications, and 
are often compared to older treatment approaches like conventional neurofeedback, 
traditional neurofeedback, standard neurofeedback, or regular neurofeedback (Collura 
2016; Koberda, Moses, Koberda, & Koberda, 2012; Thatcher, 2013; Thompson & 
Thompson, 2016; Wigton, 2013; Wigton & Krigbaum, 2015).  When reviewing the 
literature, a clear understanding of what each term entails is necessary to understand the 
efficacy of the treatment for physical and mental health conditions because more recent 
treatment approaches, technology, and applications have utility across a broader scope of 
symptoms whereas the older approaches are specific to certain conditions such as 
attention deficits (Wigton, 2013; Wigton & Krigbaum 2015).  A focus solely on the 
efficacy of neurofeedback for attention deficits (Arns, Heinrich, & Strehl, 2014) does not 
cover the vastness of physical and mental health.  
In this meta-analysis, I sought to evaluate and synthesize evidence on the efficacy 
of neurofeedback by pooling results of studies examining its efficacy for physical and 
mental health outcomes.  Specifically, I pooled the related independent studies of the use 
of neurofeedback for health and mental health conditions to critically evaluate the 
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evidence for efficacy as it exists collectively.  Card (2011) argued that rather than a need 
for continued research to propel a knowledge area forward, a more significant need rests 
in the unification of existing research that organizes and summarizes the collection of 
what we know.  In this meta-analysis, I addressed a gap in the literature by analyzing the 
results of qualifying published research (peer reviewed, editor reviewed, open access, and 
so forth) and unpublished research (conference material, working papers, case studies, 
and so forth) on neurofeedback to understand the overall efficacy of neurofeedback for 
physical and mental health outcomes (Card, 2011; Huffcutt, 2004).   
Defining the dependent and independent variables of this quantitative meta-
analysis was significant in developing the research question and hypothesis.  According 
to Trochim (2006) the independent variable is manipulated (treatment) and the dependent 
variable is affected by the independent variable (outcomes).  In this study, neurofeedback 
was the treatment (independent variable) I reviewed for efficacy in physical and mental 
health outcomes (dependent variable). 
Research Question 
RQ: What are the effects of neurofeedback on physical and mental health 
outcomes across published and unpublished studies? 
H0: Neurofeedback will not have a significant effect on physical and mental 
health outcomes as determined by meta-analysis of published and unpublished studies. 
Ha: Neurofeedback will have a significant effect on physical and mental health 
outcomes as determined by meta-analysis of published and unpublished studies.  
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Theoretical Framework 
Skinner’s (1938) theory of operant conditioning served as the theoretical base for 
this meta-analysis.  Skinner contended that the reinforcement of a behavior is likely to 
create an increase in the likelihood of that behavior repeating.  An operant, as described 
by Kobayashi, Schultz, and Sakagami (2010), is any behavior that impacts the 
environment and creates an outcome.  Operant conditioning uses reinforcement following 
a desired behavior to increase the likelihood that the behavior will repeat in the future and 
punishment following an undesired behavior to decrease the likelihood that the behavior 
will repeat in the future (King, 2016).  The significance of operant conditioning to 
physical health and mental health is in the interaction of all living beings with their 
environment.  As environments change, the outcomes of the same behaviors will change, 
creating a need for changing behaviors which requires the brain to assess and modify 
behavioral interactions as necessary (Kobayashi et al., 2010).   
The process of neurofeedback training requires regulation of brain wave activity 
by following the principles of operant conditioning.  Gunkelman and Johnstone (2005) 
described brain wave activity (brain electrical patterns) as a form of behavior.  Changing 
brain wave activity through the principles of operant conditioning is less like taking 
medication with the effects wearing off as each dose wears off and more like learning to 
ride a bicycle where your skills can become rusty when not used, though likely never 
gone entirely.  This connects to the neural plasticity of the brain, meaning that the brain is 
malleable or amenable to change, with this ability to change (or grow) lasting a lifetime 
(Gunkelman & Johnstone, 2005).  As learning occurs, the dendritic connections and 
10 
 
structure of the brain are microscopically changed.  In the case of neurofeedback, the 
EEG of the learner is used by the clinician to learn which brain waves are in excess and 
which in deficit. The clinician then creates a training plan for the learner to work on over 
a number of sessions to reduce excessive brain waves and increase those in deficit.  The 
learner is rewarded via audio and visual feedback as they learn to use their brain waves 
normally. 
Nature of the Study 
In this quantitative meta-analysis, I used statistical techniques applied to a 
systematic review combining results from each included research study (see Moher, 
Liberati, Tetzlaff, Altman, & Prisma Group, 2009).  This meta-analysis of studies of the 
efficacy of neurofeedback for physical and mental health serves as a single source of 
synthesized information researchers can reference without the need to locate multiple 
articles (Gates & March, 2016).  A quality meta-analysis follows a systematic process 
such as the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA)—guidelines I followed in this meta-analysis (see Haidich, 2010).  PRISMA 
guidelines include a 27-item checklist for information to be included in the meta-analysis 
and a four-phase flow diagram of the information to be included (Moher et al., 2009).   
I identified available relevant published and unpublished research studies and 
selected them for inclusion in this meta-analysis.  The evaluation and then statistical 
synthesis of each independent research study pooled together in this meta-analysis can 
strengthen the outcomes of the existing data potentially resting results from conflictual 
studies (Card, 2011; Gates & March, 2016; Haidich, 2010; Huffcutt, 2004). 
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The quantitative meta-analysis method was appropriate for this research because 
it presented the opportunity to review the current literature, organize the outcomes of 
varying studies, and integrate them into a single study that increases transparency in the 
field regarding the efficacy of neurofeedback treatment.  According to Haidich (2010), 
the conclusions from a meta-analysis include increasing the clinical understanding of the 
effects of the treatment and a consolidation of the outcomes from multiple studies.  The 
availability of clearer evidence regarding the efficacy of neurofeedback can potentially 
increase treatment effectiveness and decrease negative outcomes in addition to providing 
direction for areas of future research.  Increased understanding of the efficacy of 
neurofeedback across a number of published and unpublished research studies that focus 
on diverse physical and mental health outcomes can shed light on treatment effectiveness 
and which treatment approaches work for which populations and health conditions.  This 
knowledge can inform treatment efficacy and serve as a pedagogical tool for evaluating 
the body of evidence for the efficacy of neurofeedback.  Such an increase in effectiveness 
and decrease in negative outcomes presents the opportunity for improved physical and 
mental health outcomes.   
Definitions 
Effect size: Strength of the relationship between variables; quantifies the 
difference between variables.  A unit of analysis in meta-analysis (Cumming, Fidler, 
Kalinowski, & Lai, 2012). 
Health: Core requirement for safety and peace; a state of physical, emotional, and 
social well-being (World Health Organization, 2018). 
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Mental health: A state of well-being; the ability to handle normal life stress, 
work, and contribute to society (World Health Organization, 2014). 
Meta-analysis: A quantitative approach to the evaluation and synthesis of 
research that pools the statistical data of each individual research study to determine the 
overall effect size (Card, 2011). 
Neurofeedback: Use of brain wave activity to teach the brain new patterns of 
behavior which can aid in self-regulation, relaxation, efficiency, and so forth; a non-
pharmacological treatment for physical and mental health (International Society for 
Neurofeedback & Research, 2017). 
Physical health:  A state of well-being; the proper functioning of all internal and 
external body parts (World Health Organization, 2014). 
Assumptions 
In meta-analyses, researchers synthesize and quantify results of multiple 
independent research studies. In this study, I assumed that meta-analysis is a valid 
method for synthesizing the results of multiple studies in a similar body of research.  For 
example, Gates and March (2016) noted that the initial approach to systematic reviews 
and meta-analyses is qualitative as research is located and evaluated for inclusion.  Even 
with established guidelines for study selection, inclusion, and exclusion, human 
judgement is a component of the process and impacts the assumption that researchers 
with a sound methodological approach will reach the same conclusions when analyzing 
the same data.  I also assumed that meta-analytic research retains the original qualities of 
each study, allowing me to re-analyze and synthesize the data of the original phenomenon 
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(neurofeedback) accurately (see Crocetti, 2016).  Finally, I assumed that the measures 
used in the original studies were valid and reliable. 
Scope and Delimitations 
The scope of the study included examining neurofeedback literature, published or 
unpublished, which included data that could be computed for effect size or data that 
could be reviewed to inform my interpretation of effect size calculations.  Because meta-
analytic research involves synthesis and statistical computation of existing research, the 
results of the meta-analysis can only be as reliable and valid as the data from the original 
studies (Crocetti, 2016).  I excluded studies not published in English, studies that were 
older than 10 years, and previous meta-analyses or systematic reviews. 
Limitations 
Internal validity and reliability in meta-analytic research relies on the validity and 
reliability of each of the studies selected for inclusion in the meta-analysis.  Inclusion of 
studies that are of poor quality or that do not provide data appropriate to answering the 
research question threaten the internal validity of a meta-analysis (Creswell, 2014).  
Research is an imperfect process, and human and systematic errors occur even when 
effort is made to reduce them.  The external validity of a meta-analysis can be threatened 
by the predetermined inclusion and exclusion criteria if it is not specific enough to 
identify studies that are useful to answering the research question.  Inaccurate data 
extraction of each study included in a meta-analysis presents a potential threat to the 
reliability of the meta-analysis.   
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To assess the methodological rigor of studies for inclusion in a meta-analysis, 
researchers use predetermined criteria based on the methodological domains of 
participation bias, attrition bias, outcome measurement, and data analysis and reporting.  
The participation bias domain includes assessing for the population of interest, ensuring 
that its key characteristics are adequately described for and inclusion, and ensuring that 
exclusion criteria are described.  The attrition bias domain includes assessing for length 
of time sufficient for follow-up outcomes to occur (three months) and reporting missing 
participant data.  The outcome measurement domain includes assessing for an objective 
outcome definition and providing that definition in advance of intervention.  The data 
analysis and reporting domain includes assessing for alpha error and/or beta error 
specifications and including frequencies for most important data (outcomes and so forth).   
Significance 
The results of this meta-analysis may inform interventions to improve physical 
and mental health outcomes by identifying the efficacy of neurofeedback across 
populations and health conditions.  A broad range of individuals suffer from diminished 
physical and mental health. As the World Health Organization (2018) has noted, physical 
and mental health are more than the absence of disease, they are fundamental to safety 
and peace.  Thus this study of efficacious treatment options for physical and mental 
health conditions may contribute to the increased well-being of those with these 
conditions.  
Future psychology educators experienced in meta-analytic research fulfill a 
mastery learning component of the active construction of knowledge.  This experience 
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can help decrease passive learning and increase the quality and effectiveness of future 
instruction and learning (Horn et al., 2014; Ouyang & Stanley, 2014).  Effective 
instruction relies on the instructors’ ability to accurately and flexibly acquire, use, and 
share knowledge in meaningful ways that meets the needs of the learners (Ouyang & 
Stanley, 2014).  Increasing the quality of instruction and learning success for students 
offers a unique opportunity for positive social change.   
Summary 
Neurofeedback has roots dating back to the 1950s, with evolution in techniques, 
software, and hardware still occurring today, leaving inconsistencies about the details of 
the treatment and its overall efficacy (Thompson & Thompson, 2016).  In this meta-
analysis, I evaluated and synthesized the evidence regarding the efficacy of 
neurofeedback for physical and mental health outcomes.  In psychology education, it is 
important to be able to critically evaluate evidence across a diverse body of research on a 
given topic.  Meta-analysis can be an important tool for the synthesis of this evidence.  
Thus, this systematic review and meta-analysis of the efficacy of neurofeedback has 
pedagogic value in understanding the body of evidence on neurofeedback for health and 
mental health outcomes and then communicating that understanding to others working 
and studying in the field. 
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Chapter 2: Literature Review 
Introduction 
In this meta-analysis, I addressed the lack of consistency and specificity in 
previous studies about the efficacy of neurofeedback for physical and mental health 
outcomes.  There has been a diversity of findings and conflicting results on efficacy of 
neurofeedback across different physical and mental health outcomes.  I thus determined 
that it was important to synthesize the evidence across these studies to evaluate the 
strength of the evidence for the effectiveness of neurofeedback and to delineate some of 
the boundaries for the observed effectiveness reported in published and unpublished 
studies.  One or two studies with positive results can be misleading.  Meta-analysis, a 
systematic review with statistical synthesis, is the gold standard in valid and reliable 
evaluation of the strength of the evidence in the literature across a number of studies 
(Crocetti, 2016; Cumming, 2013).  The purpose of this meta-analysis was to evaluate and 
synthesize the evidence for the efficacy of neurofeedback for physical and mental health 
outcomes by conducting a systematic review with meta-analysis of published and 
unpublished studies on the topic. 
Clinical drug trials that use placebos or double-blind conditions are often the 
standard approach for determining efficacy of treatments to physical and mental health 
outcomes (Thompson & Thompson, 2016).  Unfortunately, such approaches are not 
effective for determining the efficacy of neurofeedback because the established 
conditions violate the basic principles by which neurofeedback operationalizes brain and 
behavior change (Thompson & Thompson, 2016).  For example, the inclusion of a 
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placebo condition in a clinical drug trial does not administer active medication to the 
individual, but a placebo condition in neurofeedback still involves training conditions 
with erroneous feedback (active medication) that, based on the principles of operant 
conditioning, can still result in learning (even if not desired or goal directed; King, 2016; 
Thibault & Raz, 2017).  A pharmacological placebo is a pill that lacks the active 
medication found in the non-placebo pill.  More specifically, a placebo in pharmacology 
is a pill that looks and feels like the real deal, but has no clinical function (Wang, Zhao, 
& Hao, 2017).  Since placebo (or sham) neurofeedback would have a clinical (treatment) 
function, in this meta-analysis I included study designs such as observational and 
interventional designs (cohort studies, randomized clinical trials with or without placebo 
conditions, and so forth) that are not specific to controlled conditions.  I did this so as to 
include the varying studies and approaches across the field that might increase my 
understanding of the intervention’s efficacy across diverse physical and mental health 
outcomes. 
Literature Search Strategy 
I began the literature review by searching electronic databases including Medline, 
CINAHL, PsycARTICLES, PsycINFO, SocINDEX, ScienceDirect, IEEE Xplore Digital 
Library, PubMed, and Cochrane Register of Controlled Trials.  To address publication 
bias, I also searched Clinicaltrails.gov for unpublished studies, in progress studies, 
reports, presentations, conference abstracts, and dissertations.  The Office of Human 
Research Protections (OHRP), National Institutes of Health (NIH), and the Food and 
Drug Administration (FDA) web sites were searched for clinical study data.  I searched 
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for keywords including EEG biofeedback, neurofeedback, fMRI, and meta-analysis using 
Boolean operators.  I found relevant articles in a variety of journals including Journal of 
Neurotherapy, Journal of Mental Health Counseling, Biofeedback, Neuroscience, 
Applied Pyschophysiology & Biofeedback, American Psychologist, Experimental Brain 
Research, International Journal of Psychophysiology, BRAIN: A Journal of Neurology, 
and Proceedings of the IEEE. 
Overview of the Literature Review 
Theoretical Base for Neurofeedback 
 Skinner’s (1938) theory of operant conditioning holds that humans learn through 
positive and negative consequences following a given behavior. According to Skinner, 
the reinforcement of a behavior is likely to create an increase in the likelihood of that 
behavior repeating and the punishment of a behavior is likely to create a decrease in the 
likelihood of that behavior repeating.  Operant conditioning is the driving force behind 
neurofeedback, which is designed to reward healthy brain waves and increase the 
likelihood that they will repeat.   
 Kobayashi et al. (2010) described an operant as any behavior that impacts the 
environment and creates an outcome.  The logic being that the operant can be changed 
through conditioning (i.e., operant conditioning).  The process of operant conditioning 
uses reinforcement following a desired behavior to increase the likelihood that the 
behavior will repeat in the future, or punishment following an undesired behavior to 
decrease the likelihood that the behavior will repeat in the future (King, 2016).  The 
timing of the reinforcement or punishment of the behavior is imperative for learning and 
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the desired behavior change to occur (Skinner, 1938).  Operant conditioning is significant 
to physical health and mental health due to the interaction of all living beings with their 
environment.  As environments change, the outcomes of the same behaviors will change, 
creating a need for changing behaviors, which requires the brain to assess and modify 
behavioral interactions as necessary (Kobayashi et al., 2010). 
The process of neurofeedback training involves regulation of brain wave activity 
following the principles of operant conditioning.  Gunkelman and Johnstone (2005) 
described brain wave activity (brain electrical patterns) as a form of behavior.  Changing 
brain wave activity through the learning principles of operant conditioning is less like 
taking medication with the effects wearing off as each dose wears off, and more like 
learning to ride a bicycle where your skills can become rusty when not used, though 
likely never gone entirely.  The ability to change brain wave activity connects to the 
neural plasticity of the brain, meaning that the brain is malleable or amenable to change, 
with this ability to change (or grow) lasting a lifetime (Gunkelman & Johnstone, 2005; 
Thompson & Thompson, 2016).  As learning occurs, the dendritic connections and 
structure of the brain are microscopically changed.  In the case of neurofeedback, the 
clinician uses the EEG of the learner to learn which brain waves are in excess and which 
in deficit and creates a training plan for the learner to work on over a number of sessions 
to reduce excessive brain waves and increase those in deficit.  The learner is rewarded via 
audio and visual feedback as they learn to use their brain waves normally.   
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Neurofeedback 
Neurofeedback, also known as EEG biofeedback, is a clinical treatment modality 
focused on the use of operant conditioning to train brain waves.  Wigton and Krigbaum 
(2015) described neurofeedback as a process that uses scalp sensors, an amplifier, and 
computer software to train specific brain wave frequencies that are not working in the 
target range, as noted on the EEG.  Neurofeedback, as a clinical treatment modality and 
in a specific context, can be used in conjunction with most clinical treatments such as 
psychotherapy, psychology, nursing, chiropractic care, medical care, and so forth.  
Individuals typically do not observe their own brain wave activity, but with 
neurofeedback, individuals are given the opportunity to view and hear their brain wave 
activity through the feedback provided during the training (Collura, 2016). 
Psychiatrists, psychologists, mental health counselors, and other professionals 
who diagnose and treat symptomology related to the functioning and well-being of the 
brain are surprisingly unlikely to examine the organ associated with the conditions they 
are treating.  For example, the Council for Accreditation of Counseling and Related 
Education Programs (CACREP, 2016), has standards requiring that counselors learn, 
understand, and experience neurobiological mechanisms as they relate to mental health to 
aid in the integration of neuroscience to counseling practice.  Neurobiological 
mechanisms include the relationships in an individual of the biological, neurological, and 
physiological connections that directly impact development, behavior, and functioning 
(CACREP, 2016).  Mental health practitioners should understand neuroscience because 
the brain is composed of structurally and functionally connected areas, and practitioners 
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can use observations of brain activity to distinguish healthy functioning from 
psychological and neurological disorders. (Murphy & Bassett, 2017; Sitaram et al., 
2016).  Identification of healthy brain functioning and the ability to differentiate it from 
unhealthy brain functioning increases the rate at which mental health professionals can 
identify symptomology and behavior as it correlates with healthy (or unhealthy) brain 
functioning and by extension healthy (or unhealthy) levels of daily functioning (Murphy 
& Bassett, 2017; Sitaram et al., 2016).   
Historically, a neuroscientific connection to mental health and behavior might be 
overlooked, but recently the scientific community has highlighted connections between 
the neuroplasticity of the brain and the role that psychotherapeutic counseling has on 
changing brain functioning (Ivey, Ivey, & Zalaquett, 2014).  Functional changes of the 
brain can also result from the purposeful attempt at changing brain functioning with 
neurofeedback training.  During neurofeedback training, the learner acquires the ability to 
self-regulate by decreasing or increasing brain wave functioning (as identified by the 
practitioner) towards normal as determined by a normative database (Alkoby et al., 2017; 
Chapin, 2016; Cleary, 2011; Collura, 2016; Gunkelman & Johnstone, 2005; Thompson & 
Thompson, 2016; Wigton, 2013).  As learners train with neurofeedback, they are 
presented with visual and/or auditory feedback that, based on the principles of operant 
conditioning, are meant to increase or decrease specific brain functioning. The learners 
acquire the ability to regulate brain waves and thus the ability to self-regulate and/or 
change how they interact with their environment (Alkoby et al., 2017; Chapin, 2016; 
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Cleary, 2011; Collura, 2016; Gunkelman & Johnstone, 2005; Thompson & Thompson, 
2016; Wigton, 2013).   
QEEG or Brain Mapping 
Quantitative EEG (QEEG), sometimes referred to as brain mapping, is an 
extension of EEG where the EEG is analyzed, compared to a normative database, then 
converted to a map of the brain that can assist in the clinical understanding of the current 
functioning of the brain (Demos, 2005).  The comparison of the EEG to the normative 
database is a process completed by computer software and involves specific algorithms 
and statistical analysis.  Software can vary from manufacturer to manufacturer, but 
typical analyses include power, coherence, phase, amplitude, and frequency (Soutar & 
Longo, 2011).  The QEEG is not intended for use as a diagnostic tool; rather, clinicians 
use it to (a) understand the current functioning of the brain including dysregulation, 
dysfunction or impaired function, and connectivity of and between various neural 
networks in the brain; and (b) confirm hypotheses regarding brain function in relation to 
symptoms or existing diagnoses (Soutar & Longo, 2011; Thatcher, 2016).  While a 
QEEG is not required for neurofeedback, it is the preferred method of obtaining a clinical 
assessment of the brain and it aids in protocol selection prior to neurofeedback (ISNR, 
2017; Soutar & Longo, 2011). 
 Recent technological advances have decreased some of the barriers present in 
gathering QEEG data and comparing the data to normative databases (Thompson & 
Thompson, 2016; Wigton and Krigbaum, 2015).  A normative database includes data 
collected from a selected population of individuals that met the inclusion criteria of the 
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creators of the database.  QEEG data is compared to the normative database clinicians 
use to help increase their understanding of the clinical picture of the brain they are 
reviewing.  Multiple databases are available for comparison.  For example, the 
NeuroGuide normative database includes 678 subjects ranging in age from 2 to 82 that 
met certain clinical standards based on inclusion/exclusion criteria (without a history of 
neurological or behavioral disorders, performed at grade level, completed 
neuropsychological testing, and so forth.) and utilizes 2 year means with 6 months 
overlap of subjects (Thatcher, 2016). 
 Clinicians’ use of the QEEG to better understand the patients’ current levels of 
brain functioning will also increase their understanding of the individuals as they exist in 
their daily environments and how that compares to normal or healthy.  Using the QEEG 
as part of the assessment process to then match findings to historical functioning, current 
functioning, and desired functioning is part of the documented gold standards for the field 
of neurofeedback that will potentially help to improve physical and mental health 
outcomes (Thompson & Thompson, 2016; Wigton and Krigbaum, 2015).  The alternative 
option of not using a QEEG as a part of the neurofeedback training offers a potential 
hindrance to the trainee and the overall efficacy of the approach for physical and mental 
health outcomes. 
Brain Waves and Frequency 
Brain waves are measured as the electrical activity of neurons within the brain 
(Demos, 2005).  The electrical activity of the neurons can be collected through EEG, 
which uses clinical equipment comprised of scalp sensors, an amplifier, and computer 
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system to monitor, record, and transform the electrical activity to brain wave frequency 
data (Demos, 2005; Soutar & Longo, 2011).  Each frequency is associated with specific 
behavioral characteristics.  For example, the following frequencies and their relation to 
behavior, Delta is commonly 1 to 4 Hz representing sleep, repair, problem solving, and so 
forth; Theta is commonly 4 to 8 Hz representing creativity, insight, and so forth; Alpha is 
commonly 8 to 12 Hz representing alertness, peacefulness, readiness, meditation, and so 
forth; and Beta is commonly 13-21 Hz representing thinking, focusing, sustained 
attention, and so forth (Demos, 2005).  Understanding brain activity and its connections 
to physical and mental health is critical for selecting training protocols that will increase 
functioning by brainwave regulation and simultaneously increasing physical and mental 
health (Sherlin et al., 2011; Thompson & Thompson, 2016).  A lack of understanding of 
brain functioning and activity increases the potential for ineffective training and 
iatrogenic harm (Hammond & Kirk, 2015). 
Brodmann Areas 
The 47 Brodmann areas named after their founder Korbinian Brodmann in 1909 
divide the cerebral cortex of the brain into 47 distinct regions that increase the clinical 
understanding of brain location and functioning (Soutar & Longo, 2011).  The premise of 
the 47 Brodmann areas is based on the original idea that structure is a determining factor 
of function (Thatcher, 2016).  The Brodmann areas aid in a visual representation of 
symptomology when using a QEEG brain map to view current brain functioning.  For 
example, some of the Brodmann areas connect to function as follows:  areas 1, 3, 4, and 6 
are associated with sensory and motor functions; areas 5, 7, and 19 are associated with 
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perseverance, self-awareness, orientation, agnosia, and apraxia; and areas 8, 9, and 46 are 
associated with verbal, spatial, and object short-term memory retrieval, facial recognition, 
planning, problem solving, vigilance, and some attentional characteristics (Soutar & 
Longo, 2011).   
Inverse solutions estimate the structure (source/location) of activity from the EEG 
recorded at the surface of the scalp (Thatcher, 2016).  The recording at the scalp is based 
on the specific electrode placement guided by the international 10/20 system that follows 
documented measurements beginning at four specific locations on the skull and follows a 
percentage (10% or 20%) to reach the next electrode placement destination (Thatcher, 
2016).  Talarich Atlas coordinates were used by the Human Brain Project to duplicate the 
coordinates used by Brodmann for each of the Brodmann areas and, when coupled with 
the use of the inverse solutions, these locations became easily identified in 
correspondence to electrode placements on the scalp surface when following the 
international 10/20 placement system (Thatcher, 2016).   
Excluding fMRI 
 Functional magnetic resonance imaging (fMRI) focuses on changes in blood flow 
in the brain to measure activity of the brain which is different than measuring the 
electrical activity of the brain through sensors on the scalp.  Cerebral blood flow and 
neuronal activation are coupled, thus allowing for images of brain functioning to be 
created similarly to the brain maps created by QEEG (Choi, 2013).  The equipment 
necessary for fMRI and fMRI neurofeedback is costly in comparison to that for QEEG 
and EEG neurofeedback, and currently fMRI neurofeedback is not a readily available 
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treatment for patients (Thibault & Raz, 2017).  The use of fMRI neurofeedback is utilized 
in research settings where participants learn regulation of hemodynamics specifically in 
the brain.  Treatment benefits of fMRI that compare or supplant those of EEG 
neurofeedback have yet to be established, and when added to the higher cost and reduced 
access to the fMRI equipment, fMRI neurofeedback is not included in this meta-analysis 
(Thibault & Raz, 2017).  While fMRI neurofeedback has equal potential to affect 
physical and mental health outcomes, the reduced access and increased cost would 
present significant barriers for common access to the treatment. 
History of Neurofeedback Use in Clinical Contexts 
Practice Standards 
 The Biofeedback Certification International Alliance (BCIA) (2016) professional 
standards and ethical principles of biofeedback and neurofeedback include a standard of 
practice for all practitioners with the stated intent to uphold the highest standard of the 
profession while being diligent in protecting the best welfare of all clients.  The 
Association for Applied Psychophysiology and Biofeedback (AAPB) (2008) publishes 
standards for performing biofeedback, which includes EEG biofeedback (neurofeedback) 
within the standards.  Like BCIA, AAPB (2008) highlights the intentions of the standards 
of practice to protect clients through ethical practice and adherence to laws of the 
practitioners licensing body.   
Practitioners of neurofeedback are not required to have a credential in the practice 
of neurofeedback, but are likely required to have a license to practice in their respective 
field in their home state to be a healthcare provider (AAPB 2008; BCIA, 2016).  Such a 
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reliance on individual providers to find a benefit in seeking out additional certifications 
beyond what is required presents a valid concern for unethical practices, and unethical 
practices increase the likelihood for harm as well as poor outcomes (Hammond & Kirk, 
2008).  The professional standards and ethical principles of the BCIA (2016) create an 
opportunity for the development of increased regulation, consistency, and efficacy in the 
field of neurofeedback through established practice standards that may positively affect 
health and mental health outcomes.   
Practice standards in treatment approaches are suggested to begin with a thorough 
assessment of the individual including a QEEG that is matched to historical functioning, 
current functioning, and desired future functioning (Hammond & Kirk, 2008; Thompson 
& Thompson, 2016; Wigton and Krigbaum, 2015).  Practitioners must also follow the 
ethical and practice standards for the area in which they have licensure.  Technology 
advances have increased accuracy and access in neurofeedback, but it is important to note 
that organizations including BCIA (2016), AAPB (2008), and ISNR (2017) do not 
endorse any specific product(s) (software or hardware) and rather focus on maintaining 
ethics, standards, and knowledge within the field. 
Strengths 
 A primary strength of neurofeedback rests in the fact that it is not introducing a 
chemical into the body and is an opportunity for the individual to learn to regulate his or 
her brain waves from the monitoring and feedback of the brain itself (Koberda et al., 
2012).  Like learning to ride a bicycle, neurofeedback is an opportunity for long term 
change.  A headache could be a side effect of neurofeedback, but such a side effect that is 
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a direct result of neurofeedback training can be reversed trained by the implementation of 
the opposite training protocol and thus eliminating the negative effect (Arns, et al., 2014).  
This type of brain regulation results from the internal change of brain functioning which 
is not reliant on the ingestion of a chemical that must be repeated when the effects of the 
chemical wear off.  Without the addition of new chemicals in the body, treatment 
tolerance increases and potential withdrawal symptoms decrease (Arns, et al., 2014).  
Such strengths can be appealing especially when desiring a holistic or natural approach to 
functioning that will last and prompts the necessary investigation of the relevant current 
studies to increase our understanding of the efficacy of neurofeedback for physical and 
mental health outcomes. 
Criticism 
 Side effects commonly occur with treatment interventions, even those that are 
determined to be reliably effective.  A major criticism of neurofeedback treatment is the 
lack of reported negative effects resulting from treatment (Thibault & Raz, 2017).  
Possibly, Hammond and Kirk (2008) correctly suggested that adverse or iatrogenic 
effects of neurofeedback are connected to a lack of adherence to practice standards.  This 
could explain the lack of reported negative effects considering researchers are more likely 
to avoid criticism when publish if they follow practice standards (Haidich, 2010). 
 Another major criticism of neurofeedback treatment is the documented financial 
interest of many of the researchers because they make a profit by either practicing 
neurofeedback in a clinical context selling neurofeedback equipment and software 
(Thibault & Raz, 2017).  While financial interest is not entirely uncommon in clinical or 
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pharmaceutical research, author or researcher bias can also impact outcomes towards 
their preference (Thibault & Raz, 2017).  For example, many of the board members of the 
International Society for Neurofeedback Research (ISNR) and the Association for 
Applied Psychophysiology and Biofeedback (AAPB), the two major organizations 
related to neurofeedback, maintain financial interest in neurofeedback in some capacity 
(Thibault & Raz, 2017).  On the other hand, such financial investment could signify deep 
interest in the field based on research and outcomes that indicate efficacy and positive 
change. 
Side Effects and Placebo 
 The most simplistic consideration for the placebo effect is that all treatments can 
have a placebo effect (Demos, 2005).  The risk of the placebo effect driving positive 
results exists especially when considering that research participants are likely to want and 
expect a treatment to work (Thibault & Raz, 2017).  The placebo effect has the potential 
to mask less than effective treatments as participants likely want their symptomology to 
improve and as such, their hope and desire for improvement could be enough to convince 
them change has occurred.  Research in the benefits of neurofeedback treatment over 
placebo or sham treatment effects have yet to make a compelling enough case for 
neurofeedback to become a recognized clinical standard of care (Thibault & Raz, 2017).   
The overestimation of treatment effects in relation to mental health treatment is 
noted by Cuijpers and Cristea (2016) to be common.  Evidence does exist that purports 
benefits of neurofeedback, but not with enough specificity to separate positive treatment 
effect from placebo effect (Thibault & Raz, 2017).  It is helpful to have clarification that 
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neurofeedback treatment outcomes are not likely to be overestimated given it is not yet a 
clinical standard of care and perhaps a meta-analysis of the independent studies can 
increase available documentation on the efficacy of the treatment for physical and mental 
health outcomes.   
Neurotransmitters (chemical brain activity) have been documented to be altered 
through placebo treatment/effect, making a case for the level of difficulty that could be 
involved in separating the effectiveness of neurofeedback treatment from placebo 
(Thibault & Raz, 2017).  A final noteworthy consideration is the idea of a placebo 
network that works with the hippocampus which may result in improvements to memory 
and validate that the placebo effect might be beneficial to brain plasticity and 
improvement (Thompson & Thompson, 2016). 
Iatrogenic Harm 
 Iatrogenic harm is harm that results from the interaction of the individual with the 
medical community either from the treatment or from the clinician.  Without 
neurofeedback being accepted as a clinical standard of care, the risk of iatrogenic harm 
increases with the administration of neurofeedback treatment as the clinician is opting to 
not follow the clinical standard of care (Thibault & Raz, 2017).  Another consideration 
that can be made by clinicians is that treatments need to be tried to determine clinical 
utility and to prove effectiveness prior to becoming a standard of care, which does not 
necessarily indicate that iatrogenic harm will result from the use of neurofeedback 
treatment.  Cuijpers and Cristea (2016) warn that in determining clinical effectiveness of 
new treatments, even with clinical trials, it is still possible (even likely) that researchers 
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and clinicians can manipulate the circumstances to obtain favorable results while 
retaining the failsafe of only publishing favorable outcomes.  Thompson and Thompson 
(2016) argued that neurofeedback is not a drug and cannot be researched in the same way 
as a drug with clinical trials that use blinding or placebo.  A placebo in neurofeedback 
does not exist as a sugar pill exists for pharmacology; a placebo in neurofeedback 
administers neurofeedback where the learner would view feedback from a brain other 
than their own, during which time they could operantly learn to dysregulate their brain 
functioning (King, 2016; Thibault & Raz, 2017; Thompson & Thompson, 2016).  This is 
neither safe nor conducive to determining the efficacy of the treatment. 
 Specific considerations about why neurofeedback might present adverse or 
iatrogenic effects were presented by Hammond and Kirk (2008) and include an increase 
in unqualified professionals providing treatment, a lack of emphasis on standards of 
practice within the field, providers not seeking competency and continuing education 
trainings, and licensed healthcare providers who choose not to obtain a neurofeedback 
certification.  Thompson and Thompson (2016) argued that researchers unfamiliar with 
the underpinnings of how brain change through brain wave regulation occurs are in a 
position to incorrectly dismiss independent research studies that do not include blinding 
or placebo conditions and in doing so overlook a significant portion of the clinical 
research on the treatment that could increase the overall understanding of the efficacy of 
the treatment. 
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Neurofeedback in Physical and Mental Health  
 Physical and mental health influence one another and affect the overall well-being 
of the individual.  A goal of the brain and body is homeostasis, stability or regularity 
within the system and its functioning, which can increase the predictability and 
consistency of the individual within their environment (Thompson & Thompson, 2016).  
As environments change (home, work, school, and so forth), similar behaviors elicit 
differing outcomes that create a need to change behaviors, requiring the brain to assess 
and modify how the individual should interact with the environment to achieve 
homeostasis (Kobayashi et al., 2010).  If the body symbolizes physical health and the 
brain symbolizes mental health, it is the interaction and cooperation of both that results in 
overall well-being (homeostasis).  Neurofeedback works to achieve brain wave 
regulation, which is likely to be a state of homeostasis for the brain.  Achieving stability 
and regularity in the functioning of the brain is likely to have a positive impact on the 
functioning of the body, thus resulting in increased overall health and well-being.   
 Neurofeedback offers the opportunity for the brain to learn to function with less 
instability and dysregulation.  According to Thompson and Thompson (2016), research 
has documented increased gray and white matter volume in the brain as a result of 
neurofeedback training.  Once learning has occurred (like learning to ride a bicycle), it is 
no longer necessary to continue with the treatment.  An example presented by Thompson 
and Thompson (2016) for offering neurofeedback as a business model is that repeat 
business is not likely because once learning has occurred, the need for the treatment no 
longer exists.  The potential for neurofeedback to positively affect physical and mental 
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health indicates a need to understand the overall efficacy of the treatment for physical and 
mental outcomes. 
Neurofeedback Procedures 
International 10/20 System of Electrode Placement 
 The international 10/20 system of electrode placement dictates the specific 
location of the scalp to place the electrode to be used in the recording of EEG data 
(Thatcher, 2016).  The 10/20 references the percentage, 10% or 20%, of distance between 
scalp locations of the electrodes (typically 19) used for recording brain activity beneath 
the scalp (Marzbani et al., 2016).  Two electrodes are used for a ground and reference 
electrode.  This standard system of measurement creates consistency in acquired data 
from brain activity by ensuring that electrodes are placed in specific positions on the 
scalp and correspond to the specific cerebral location beneath the scalp. 
Training by Channel 
 Neurofeedback training can be done utilizing a single channel and commonly uses 
19 channels placed on the scalp using the international 10/20 system (Thompson & 
Thompson, 2016).  Each channel is placed on the scalp with an electrode and is 
connected to an amplifier that records and transmits the EEG data to a computer.  An 
increase in the number of channels used in training increases the number of potential 
areas of the brain that can be trained simultaneously.  This increase also signifies an 
increase in the number of potential protocols that can be selected for training.  One 
possible advantage to the use of 19 channels is that it can reduce the overall number of 
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sessions required for learning to occur, and with fewer required sessions the likelihood of 
early termination reduces (Wigton, 2013). 
QEEG Guided 
 Neurofeedback that is guided by a QEEG requires that a QEEG be completed 
prior to the neurofeedback training.  The clinician doing the neurofeedback training does 
not need to be the clinician completing the QEEG.  The clinician conducting the 
neurofeedback training must create protocols for training from the information acquired 
from the QEEG, client symptomology, clinical assessment, and so forth.  The training is 
completed over a number of sessions and then another QEEG is requested to determine 
current treatment effectiveness and directions for continued training (Wigton, 2013).   
Live Z-Score 
 Live z score neurofeedback begins with a QEEG prior to each training session to 
allow for the data of the brain at that time to be compared to the normative database and 
then to allow for protocol selection of neurofeedback training (Wigton & Krigbaum, 
2015).  The primary goal of all live z score neurofeedback training sessions is to train 
towards normalization of the QEEG (z = 0) in a way that is tailored for each client at each 
session (Wigton & Krigbaum, 2015).  Clinicians can select the number of channels (1-
19), or more specifically, which channels to include in training protocols based on the 
information from the current QEEG.  Using 19 channel z score neurofeedback offers the 
potential opportunity to decrease the total number of neurofeedback sessions required and 
to decrease the frequency of the number of neurofeedback sessions necessary weekly 
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while simultaneously increasing QEEG normalization and improving symptomology 
(Wigton & Krigbaum, 2015).   
LORETA 
 Low resolution electromagnetic tomography (LORETA) neurofeedback is a type 
of neurofeedback that uses all 19 channels to record and monitor brain wave activity 
creating a 3-dimensional correspondence of the brain with the Brodmann areas and a 
reference magnetic resonance image (MRI) (Thatcher, 2016).  Hubs, modules, and 
networks with the brain and Brodmann areas including phase, coherence, and symptoms 
are considered for neurofeedback training when utilizing LORETA neurofeedback.  
When using LORETA neurofeedback, specific brain networks can be targeted, such as 
the attention network, addiction network, default mode network, and so forth, which are 
connected to the Brodmann areas affecting connectivity between areas of the brain, and 
can be trained simultaneously (Thompson & Thompson, 2016).   
Prior Meta-Analyses and Systematic Reviews 
 Neurofeedback has been researched in varying populations with differing physical 
symptomology (physical health) and psychological diagnoses (mental health) in single 
studies.  While each individual study is useful to the field and for physical and mental 
health outcomes, a collective view of the outcomes of those studies can provide a clearer 
picture of the state of the art and its overall combined efficacy for physical and mental 
health outcomes.  I located and examined a total of six meta-analyses and systematic 
reviews of biofeedback and neurofeedback to determine the need for this meta-analysis.   
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Of the six studies, Tan et al., (2009) focused on neurofeedback specifically used 
in the treatment of epilepsy and seizures.  Even with positive outcomes for neurofeedback 
reported, the meta-analysis by Tan et al., (2009) is not current and has a limited focus for 
considering the overall efficacy of neurofeedback for physical and mental health 
outcomes.  Schoenberg and David (2014) systematically reviewed sixty-three articles of 
both biofeedback and EEG biofeedback for psychiatric disorders.  This review is current, 
within the last five years, but includes biofeedback modalities like electromyograph 
(EMG) biofeedback, heart rate variability (HRV) biofeedback, heart rate (HR) 
biofeedback, electrodermal (EDA) biofeedback, and thermal biofeedback, as well as EEG 
biofeedback (neurofeedback) for specific psychological diagnoses.  The remaining four 
studies focused on fatigue and cognition (Luctkar-Flude and Groll, 2015), what to do and 
what not to do for neurofeedback training (Rogala et al., 2016), on neurofeedback for 
optimizing athletic performance (Mirifar et al., 2017), and on neurofeedback for 
cognitive rehabilitation following a stroke (Renton et al., 2017).  These reviews offer 
information that is useful for physical and mental health outcomes in each specific area 
reviewed but fail to offer an overall understanding of the efficacy of neurofeedback for 
physical and mental health outcomes.   
Excluding ADHD 
 The American Academy of Pediatrics (2013) lists biofeedback as a level 1 
intervention for attention and hyperactivity behaviors.  A level 1 intervention, according 
to the American Academy of Pediatrics (2013), is a best support intervention that is 
supported by at least two randomized trials supporting the efficacy of the treatment as 
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superior to placebo or alternative treatments and demonstrates adequate statistical power 
with significant pre to post study change.  In an evaluative review of ADHD treatment by 
neurofeedback, Arns et al. (2014) found clinical effectiveness in the use of neurofeedback 
treatment for ADHD including what they have determined to be lasting effects.  Arns et 
al. (2014) concluded their review noting that neurofeedback for ADHD treatment should 
be considered evidence-based treatment.  In this regard it is not necessary to include 
neurofeedback for ADHD in this meta-analysis as using neurofeedback for ADHD 
treatment is evidenced to increase current physical and mental health outcomes for 
individuals and communities. 
Summary and Conclusions 
 Since the 1950s, neurofeedback has continued to evolve in technique, software, 
and hardware, leaving considerable debate about efficacy.  The treatment approach has 
been identified by the American Academy of Pediatrics (2013) as a level 1 intervention 
for attention and hyperactivity behaviors and by Arns et al. (2014) as efficacious in 
treating ADHD.  Beyond efficacy in ADHD, the literature has yet to establish the 
efficacy of neurofeedback for physical and mental health outcomes.  Considering the 
evolution of the field, including the new technologies and approaches, as well as new 
studies not included in meta-analytic studies, it is possible that neurofeedback can 
effectively treat various physical and mental health conditions.  Cumming (2013) referred 
to meta-analysis as the estimation of the effect across multiple studies resulting in 
information that is practical and usable for researchers and clinicians as meta-analysis 
answers broad questions about effectiveness (how large, how many, to what extent) 
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rather than typical yes or no questions presented by null hypothesis significance testing 
which are frequently misleading.  The results of the meta-analysis offer a much-needed 
analysis of the state of the art for the efficacy of physical and mental health conditions, 
other than ADHD.   
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Chapter 3: Research Method 
Introduction 
 When conducting systematic reviews, researchers follow a distinct methodical 
and systematic approach to selecting and reviewing existing research studies to critically 
analyze the studies’ data using statistical calculations to integrate and synthesize those 
data (Moher et al., 2009).  Researchers give thoughtful consideration to the selection and 
review of the existing studies, including the procedures used for selection, data 
collection, coding, and statistical analysis, because these methods lend to the quality, 
significance, and outcomes of the meta-analysis.  The quality of a systematic review and 
meta-analysis can be improved by following established guidelines such as the PRISMA 
guidelines (Gates & March, 2016).  Systematic reviews and meta-analyses serve as 
research evidence that is likely to be used by practitioners in a field of study to maintain 
current information to make informed decisions for assessment, diagnosis, treatment, and 
future research (Gates & March, 2016). 
Research Design and Rationale 
 I used quantitative meta-analysis to investigate the efficacy of neurofeedback for 
physical and mental health outcomes because the meta-analysis presented the opportunity 
to synthesize the results of multiple studies into a single source with data quantified via 
overall effect size (Huffcutt, 2004).  Meta-analytic research is an important tool in 
psychology education because the critical evaluation of evidence across a diverse body of 
research on a topic is a valuable and necessary skill in the discipline.  This systematic 
review and meta-analysis of the efficacy of neurofeedback has pedagogic value for 
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educators working to provide instruction on the body of evidence on neurofeedback 
rather than focusing on a few pivotal studies. 
 A single research study may show statistical significance, whereas a meta-
analysis pools meaningful data, including those regarding potential benefits of a 
particular treatment, from much of the existing available research to arrive at an overall 
look at the state of the art as a whole (Haidich, 2010).  The synthesized data provided 
evidence to either support the use of neurofeedback for physical and mental health 
interventions, or to show the inefficacy of neurofeedback for these interventions.  In this 
meta-analysis, I provide practical suggestions for current decisions regarding the use of 
neurofeedback and suggest directions for future primary research. 
Methodology 
Selection Criteria 
 In accordance with the Walden University institutional review board approval 
number 06-13-18-0138407, I proceeded with the following processes for this meta-
analysis.  My primary goal for the literature search was to locate all scientific research 
studies published or unpublished on the use of neurofeedback for physical and mental 
health.  This identification and selection of studies for inclusion in the meta-analysis 
followed a series of predetermined steps, including maintaining records of how studies 
were selected or rejected for inclusion in the final sample used for meta-analysis.  I used 
the PRISMA guidelines flowchart shown in Figure 1.  This flowchart represents the study 
selection process as it progressed from identification to screening, then to eligibility, and 
finally to those studies included in the meta-analysis (see Gates & March, 2016).  In 
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accordance with PRISMA guidelines for stating eligibility criteria for study inclusion or 
exclusion, I included as many studies as possible, excluding only those that did not meet 
the criteria for inclusion.  Studies that were not appropriate for data extraction for the 
meta-analysis and studies that lacked data appropriate for calculating effect sizes were 
not eligible for inclusion in the meta-analysis, but I reviewed them for information on 
interpreting effect size calculations.  I also reviewed these studies for advice in reporting 
directions for future research. 
I searched the following electronic databases for studies to include in the meta-
analysis including Medline, CINAHL, PsycARTICLES, PsycINFO, SocINDEX, 
ScienceDirect, IEEE Xplore Digital Library, PubMed, clinicaltrials.gov, OHRP, NIH, 
FDA, and Cochrane Register of Controlled Trials.  Keywords searched included EEG 
biofeedback, neurofeedback, fMRI, and ADHD.  For the latter two, I used the Boolean 
operator NOT to reduce the number of studies that would need to be excluded later.   
After studies were identified for possible inclusion in the meta-analysis, I 
reviewed abstracts of those studies for inclusion and exclusion criteria.  For inclusion in 
the meta-analysis, studies needed to be (a) published in English; (b) published within the 
previous 10 years (if published); (c) quantitative, empirical studies (not meta-analysis or 
reviews) of only human subjects; and (d) on a specified method or protocol of 
neurofeedback.  Duplicate studies, qualitative studies, reviews, meta-analyses, editorials, 
and expert opinion articles were excluded from this meta-analysis.  Published studies 
included peer reviewed publications and unpublished studies included gray literature 
documents such as conference proceedings, clinical trials in progress, clinical trials not 
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published, reports, and dissertations.  Studies that appeared to meet the inclusion criteria 
after I reviewed the abstracts and were available in full-text were further analyzed to 
determine if inclusion criteria were met.  The studies that did not report means, standard 
deviations, correlation coefficients, or t-test data that could be used to calculate effect 
sizes were excluded.  After these steps were completed, the remaining studies were 
marked for inclusion in the meta-analysis.   
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Figure 1. PRISMA meta-analysis flowchart. 
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Records identified through database 
searching (n = 2397) 
SCIENCE DIRECT (n = 214) 
COCHRANE (n = 103) 
MEDLINE (n = 715) 
CINAHL (n = 94) 
PSYCARTICLES (n = 10) 
PSYCINFO (n = 827) 
SOCINDEX (n = 22) 
IEEE XPLORE (n = 327) 
PUBMED (n = 85) 
Records after duplicates removed (n = 1879 = 174 + 87 + 564 + 94 + 6 + 335 + 14 + 325 + 78 + 
126 + 31 + 19 + 26) 
Potentially eligible full-text articles 
 (n = 312) 
Retrieved for more detailed assessment 
Articles included (n = 21)  
Records excluded (n = 1567) 
fMRI or ADHD (n = 280) 
Editorial, commentary, review, meta-analysis (n = 155) 
Non-Human Subjects (n = 4) 
Qualitative (n = 34) 
No NFB or combination/multiple intervention (n = 511) 
No outcome of interest (n = 147) 
Reference Not Available (n = 38) 
NFB method or protocol not specified (n = 91) 
Follow up < 3 months (n = 257) 
Insufficient statistical data (n = 50) 
Records excluded after full-text screening (n = 291)  
No Outcome of interest (n = 43) 
No specified method or protocol of Neurofeedback (n = 20) 
Insufficient statistical data (n = 51) 
Follow up < 3 months  (n = 153) 
Combined outcome intervention data (n = 3) 
Editorial, commentary, review, meta-analysis (n = 3) 
The intervention is not the main focus of the study (n = 3) 
Full report could not be retrieved (n = 15) 
Gray Records identified (n = 249) 
 
Conference Abstracts (n = 157) 
Clinical Trials (n = 36) 
Dissertations (n = 23) 
Reports (n = 33) 
Records added 
through manual 
search  (n = 0) 
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Data Extraction and Analysis  
 Each study meeting the inclusion criteria was organized and manually coded by 
data format (sample size, means and standard deviations, correlations, and t-tests).  Effect 
sizes for Cohen’s d were manually calculated for each outcome.  The newest version of 
Comprehensive Meta-Analysis (CMA, 2015) software Version 3 was used to compute 
the statistical analyses for the meta-analysis.  CMA (2015) accepts multiple data formats 
(sample size, means and standard deviations, correlations, and t-tests) for computation of 
effect size and confidence intervals.  Once each study was organized and coded by data 
format and outcomes, I entered the data into the spreadsheet interface in CMA (2015) for 
computation of the meta-analysis including data statistics for each study; Hedges’ g and 
confidence intervals at 95%.   
Effect Size Calculation and Statistical Procedures 
 Research studies included in the meta-analysis based on the criteria had available 
statistical data including sample size, means, standard deviations, effect size, correlation 
coefficients, or t-test data that I used for new statistical calculations to address the 
research question in this meta-analysis: What are the effects of neurofeedback on 
physical and mental health outcomes?  Research case studies that included statistical 
data, could be calculated to determine an estimated effect size, and met the inclusion 
criteria were included and calculated for the estimated effect size.    
Threats to Validity 
 Internal validity in a meta-analytic research study is based on the compilation of 
each of the independent research studies included.  Threats to the internal validity of this 
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study could have occurred when an included research study was not of good quality or 
did not provide data appropriate for answering the research question (see Creswell, 
2014).  Because a meta-analysis involves the synthesis and calculation of data from all 
included studies, any imperfection in a single included study may negatively impact the 
resulting outcomes.  Since research is not a perfect process, even when significant effort 
is exerted to reduce imperfections in a study, human and systematic error are always 
possible.  These internal threats to validity are difficult if not impossible to control for in 
a meta-analysis, indicating the need for researchers to follow predetermined guidelines 
for study selection and to evaluate each research study for quality and fit into the meta-
analytic research.  Any determined bias can be considered when reporting the final 
interpretation of the overall meta-analytic study outcomes (Card, 2011).   
 Threats to the external validity of a meta-analysis present when the included 
studies are not generalizable to the broader population.  I designed this meta-analysis to 
determine the efficacy of neurofeedback for physical and mental health outcomes, with 
documented support for the exclusion of fMRI neurofeedback and ADHD.  An example 
of threats to the external validity of this meta-analysis would be the inclusion of research 
that is focused on fMRI neurofeedback or ADHD, as these characteristics are not 
generalizable to the types of neurofeedback included nor to the population that might 
benefit from the results of this meta-analysis.  The clinical populations receiving fMRI 
neurofeedback or neurofeedback for ADHD are not reflective of the typical population to 
which this meta-analytic study can be generalized.  As such, I guarded against threats to 
external validity by excluding treatment variations and populations that were not of 
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interest when answering the research question.  Studies with different designs, different 
patients, and different symptomology (outside of ADHD) were included to allow for 
increased generalizability, another measure for ensuring external validity. 
Threats to Reliability 
 Reliability in research is defined as research that can be repeated in the future 
yielding the same or similar results given the same study conditions.  A meta-analysis, 
begins with data extracted from each independent research study included.  Threats to the 
reliability in this meta-analysis included the potential for inaccurate data extraction of 
each independent research study included.  A potential solution could have been to use 
more than one researcher, but this was not practical for this meta-analytic dissertation.  
The alternative I chose was to review the extracted data from each of the independent 
research studies on two separate occasions, which proved to be a practical solution for 
this meta-analysis (see Card, 2011). 
Ethical Procedures 
 As part of the systematic review and literature selection process, I reviewed 
studies for ethical treatment of the participants.  Given the nature of meta-analytic 
research utilizing secondary data, I did not directly use participants in data collection.  
The data that was used in the meta-analysis was pooled from statistical data of the 
included researched studies, which was data that had been previously collected from 
participants.  Given that participants were not used in this meta-analysis because it used 
secondary data, ethical treatment of the participants was not a concern. 
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Summary 
  This study consisted of a meta-analysis of published and unpublished research 
into the efficacy of neurofeedback for physical and mental health outcomes.  I followed a 
strategized plan for locating relevant studies in this chapter (see Figure 1).  Table 1, 
included in chapter 4, outlines the major characteristic qualities of the research that I 
compiled for inclusion in this meta-analysis.  I analyzed the extracted data with CMA 
(2015) software specifically designed for the statistical analyses involved with meta-
analytic research.  Chapter 4 includes the results and interpretations of the statistical 
analyses as they connect to the original research question.  The results and interpretations 
of this meta-analysis that I reported in chapter 4 create the foundation for the conclusions 
about the efficacy of neurofeedback for physical and mental health outcomes in chapter 
5. 
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Chapter 4: Results  
In this meta-analysis, I addressed the overall efficacy of neurofeedback for 
physical and mental health outcomes while acquiring pedagogic value in understanding a 
body of evidence.  According to the World Health Organization (2018) physical and 
mental health outcomes are important to society in areas of existence like safety and 
peace.  Neurofeedback offers an innovative approach to physical and mental health, yet 
its efficacy has remained unclear in the clinical research (Alkoby et al., 2017; Marzbani 
et al., 2016).   
In this study, I aimed to determine the effects of neurofeedback on physical and 
mental health outcomes across published and unpublished studies.  To determine the 
efficacy of neurofeedback, I developed the following research question for this meta-
analysis: What are the effects of neurofeedback on physical and mental health outcomes 
across published and unpublished studies?  The hypothesis was that neurofeedback has a 
significant effect on physical and mental health outcomes across published and 
unpublished studies, and the null hypothesis was that neurofeedback does not have a 
significant effect on physical and mental health outcomes as determined by a meta-
analysis of published and unpublished studies.   
I included the results from 21 studies with neurofeedback used as a physical and 
mental health intervention for obesity, depression, attention in intellectual disability, 
intelligence, insomnia, food craving, dysgraphia, autism, clinical personality 
accentuations in alcohol use disorder, pain, peripheral neuropathy in cancer survivors, 
fibromyalgia, tinnitus, and so forth.  A total of 756 participants were included across the 
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21 studies ranging in age from six to 80.  In this chapter, I present data collection 
procedures, study data of each included study, data management procedures, and results 
of the meta-analysis.     
Data Collection 
I conducted a literature search for English-language publications on the use of 
neurofeedback for physical or mental health outcomes, excluding ADHD and fMRI.  I 
attempted to collect all scientifically relevant investigations on the use of neurofeedback 
for physical and mental health outcomes including published and unpublished studies.  
To reduce the potential for bias, published studies included peer reviewed publications 
and unpublished studies included gray literature documents such as conference abstracts, 
clinical trials in progress and not published, reports, and dissertations.   
The initial searches of academic databases led me to the following results (by 
database): ScienceDirect (n = 214), Cochrane Register of Controlled Trials (n = 103), 
Medline (n = 715), CINAHL (n = 94), PyscARTICLES (n = 10), PsycInfo (n = 827), 
SocINDEX (n = 22), IEEE Xplore Digital Library (n = 327), PubMed (n = 85), and the 
following for unpublished studies clinicaltrials.gov, OHRP, NIH, FDA, resulting in 
conference abstracts (n = 157), clinical trials (n = 36), dissertations (n = 23), and reports 
(n = 33; see Figure 1).   
Keywords searched included EEG biofeedback, neurofeedback, fMRI, and ADHD.  
For the latter two, I used the Boolean operator NOT to reduce the number of studies that 
would need to be excluded later.    In addition to limiting the searches to English-
language publications, I also limited the searches to studies published within the last 10 
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years (from 2009), and studies involving human subjects.  I did not include books, but did 
include conference papers and presentations, magazine articles, dissertations, early access 
articles, and clinical trials.  This search resulted in an initial body of references totaling 
2,397 sources.  After the removal of duplicates, 1,879 sources remained. 
A goal of meta-analysis is to include as many scientifically relevant sources as 
possible.  With this goal in mind, I predetermined specific inclusion and exclusion 
criteria to maintain the integrity and quality of the results of the meta-analysis.  As such, 
my review of the 1,879 article abstracts resulted in exclusion of 1,567 articles because 
they did not meet the inclusion criteria described in Chapter 3.  Studies excluded with no 
outcome of interest include those with a primary intervention of EEG biofeedback, EMG 
biofeedback, or those using EEG to measure brainwave patterns or changes during 
varying tasks such as meditation, guided imagery, drawing, playing video games, and so 
forth, but that did not use neurofeedback as an intervention for physical or mental health 
outcomes.  Studies excluded for insufficient statistical data include those that did not 
report means, standard deviations, correlation coefficients, or t-test data that could be 
used to calculate effect sizes.  Reasons for article exclusion are as follows: editorial, 
commentary, review, and meta-analysis articles (n = 155); fMRI or ADHD (n = 280); 
non-human subjects (n = 4); qualitative (n = 34); no neurofeedback or combination 
intervention (n = 511); no outcome of interest (n = 147); neurofeedback method or 
protocol not specified (n = 91); follow up under 3 months (n = 257); insufficient 
statistical data (n = 50); and reference abstract not available (n = 38).  A total of 312 
studies remained for full text retrieval and review.  
51 
 
During the full text review of the 312 studies, 291 studies did not fit the inclusion 
criteria and were excluded.  Studies excluded with no outcome of interest include those 
with a primary intervention of EEG biofeedback, EMG biofeedback, or those using EEG 
to measure brainwave patterns or changes during varying tasks such as meditation, 
guided imagery, drawing, playing video games, and so forth, but do not use 
neurofeedback as an intervention for health or mental health outcomes.  Studies excluded 
for insufficient statistical data include those that did not report means, standard 
deviations, correlation coefficients, or t-test data that could be used to calculate effect 
sizes.  Of the 291 excluded studies, reasons for exclusion were as follows: editorial, 
commentary, review, and meta-analysis articles (n = 3); no specified method or protocol 
of neurofeedback (n = 20); no outcome of interest (n = 43); combined outcome 
intervention data (n = 3); follow up under 3 months (n = 153); insufficient statistical data 
(n = 51); the intervention is not the main focus of the study (n = 3); and full report could 
not be retrieved (n = 15).  Thus, I included 21 published studies and 0 unpublished 
studies.   
I manually searched the references lists of the 21 studies included in the meta-
analysis for additional studies meeting the inclusion criteria for this meta-analysis.  Six 
articles were selected from the manual review of included studies to be pulled for further 
review.  After further review of the six articles, I found that none met the inclusion 
criteria.  Two lacked a follow up of three months, three did not have sufficient statistical 
data, and one article could not be retrieved in full text.   
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Table 1 illustrates the major characteristics of the studies included in the meta-
analysis.  Of the 21 studies, six were conducted in the United States with U.S. 
participants, and the remaining 15 studies were conducted outside of the United States.  A 
single study had more the 100 participants, 6 studies had up to 51 participants, 12 studies 
had up to 26 participants, and 2 studies had between 62 and 70 participants.  Six studies 
used up to 19-channel neurofeedback training, the remaining used four or fewer channels 
for training, with single-channel training being the most commonly used (at eight 
studies).  Eleven studies included QEEG, and the average number of neurofeedback 
training sessions across the 21 studies was 32.5 sessions.  Interestingly, the highest 
number of neurofeedback training sessions was used in combination with up to 19-
channel training and QEEG, with up to 160 sessions in one study, up to 120 sessions in 
another, then up to 84, up to 59, and 48 in others.  This seems to contradict the idea that 
the use of QEEG and up to 19-channel training in session can reduce the number and 
frequency of neurofeedback sessions required to create symptomology improvement 
(Wigton & Krigbaum, 2015).  
 53 
 
Table 1 
 
Major Characteristics of the Studies Included in the Meta-Analysis (N = 21) 
Reference Total 
N 
Design USA 
or 
non-
USA 
EEG 
neurofeedback 
for: 
# of scalp 
training 
electrodes 
# of 
neurofeed
back 
sessions 
QEEG 
used 
Outcome measure(s) Health 
or 
mental 
health 
Chirita-
Emandi and 
Puiu (2014) 
34 Controlled 
pilot 
Non-
USA 
Obesity 3 20 No Eating behavior 
(TFEQ) and quality 
of life (KINDL) 
Health 
and 
mental 
health 
Crocetti, 
Forti, and Del 
Bo (2011) 
15 Case 
controlled 
Non-
USA 
Tinnitus 4 12 No Tinnitus Handicap 
Inventory (THI) 
Mental 
health 
Dalkner et al. 
(2017) 
25 Controlled 
study 
Non-
USA 
Clinical 
personality 
accentuations 
in Alcohol Use 
Disorder 
(AUD) 
3 12 No Inventory of Clinical 
Personality 
Accentuations (ICP) 
and the NEO Five 
Factor Inventory 
(NEO-FFI) 
Mental 
health 
Hammer, 
Colbert, 
Brown, and 
Ilioi (2011) 
8 Pre-post 
pilot 
USA insomnia 2 15 Yes Pittsburgh Sleep 
Quality Index –Total 
(PSQI-T) 
Health 
Hong, and  
Lee (2012) 
14 Controlled 
trial 
Non-
USA 
Intellectual 
disability 
(attention) 
3 36 No Children’s color 
trails test -2, stroop 
color and word test, 
and digit span test 
Mental 
health 
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Reference Total 
N 
Design USA 
or 
non-
USA 
EEG 
neurofeedback 
for: 
# of scalp 
training 
electrodes 
# of 
neurofeed
back 
sessions 
QEEG 
used 
Outcome measure(s) Health 
or 
mental 
health 
Imperatori et 
al. (2017) 
50 Randomize
d 
controlled 
trial 
Non-
USA 
Food craving 
(non-clinical 
sample) 
1 10 Yes Food Cravings 
Questionnaire-Trait 
(FCQT) and Global 
Severity Index (GSI) 
Health 
and 
mental 
health 
Jensen et al. 
(2013) 
10 Pre-post 
case series 
USA Spinal Cord 
Injury (SCI) 
and chronic 
pain 
2 12 Yes 0-10 Numerical 
Rating Scale of pain 
intensity (NRS-11) 
Health 
Kayıran et al. 
(2010) 
36 Randomize
d 
controlled 
trial 
Non-
USA 
Fibromyalgia 1 20 No Visual Analogue 
Scale (VAS) for 
pain, VAS for 
fatigue, Hamilton 
Depression Scale 
(HDS), Beck 
Depression Scale 
(BDS), Hamilton 
Anxiety Scale 
(HAS), and Beck 
Anxiety Scale 
(BAS) 
Health 
and 
mental 
health 
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Reference Total 
N 
Design USA 
or 
non-
USA 
EEG 
neurofeedback 
for: 
# of scalp 
training 
electrodes 
# of 
neurofeed
back 
sessions 
QEEG 
used 
Outcome measure(s) Health 
or 
mental 
health 
Kouijzer et 
al.(2010) 
20 Randomize
d 
controlled 
trial 
Non-
USA 
Autism 
Spectrum 
Disorders 
(ASD) 
1 40 Yes Social 
Communication 
Questionnaire 
(SCQ), Social 
Responsiveness 
Scale (SRS), 
Children’s 
Communication 
Checklist (CCC-2) 
Mental 
health 
Kouijzer et al. 
(2013) 
13 Randomize
d 
controlled 
trial 
Non-
USA 
Autism 
Spectrum 
Disorders 
(ASD) 
1 40 Yes Social 
Communication 
Questionnaire 
(SCQ), Trail Making 
Test (TMT), stroop 
task, Tower of 
London (TOL), Test 
of Sustained 
Selective Attention 
(TOSSA), digit span 
from the Wechsler 
Intelligence Scale 
for Children 3rd 
version (WISC-3) 
Mental 
health 
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Reference Total 
N 
Design USA 
or 
non-
USA 
EEG 
neurofeedback 
for: 
# of scalp 
training 
electrodes 
# of 
neurofeed
back 
sessions 
QEEG 
used 
Outcome measure(s) Health 
or 
mental 
health 
Prinsloo et al. 
(2018) 
62 Randomize
d 
controlled 
trial 
USA cancer 
survivors with 
Chemotherapy
-Induced 
Peripheral 
Neuropathy 
(CIPN) 
symptoms 
≤19 20 Yes MD Anderson 
Symptom Inventory 
(MDASI), 36-Item 
Short Form Survey 
(SF-36), Brief 
Fatigue Inventory 
(BFI), and 
Pittsburgh Sleep 
Quality Index 
(PSQI) 
Health 
Saki, 
Davoodi, 
Nosratabadi, 
and 
Yadollahpour, 
(2016) 
10 Controlled 
trial 
Non-
USA 
Tinnitus Not 
specified 
15 No Tinnitus Severity 
Index (TSI) and 
Tinnitus 
Questionnaire (TQ) 
Mental 
health 
Sokhadze and 
Daniels 
(2016) 
11 Pre-post 
case series 
USA Prevent drug 
abuse; increase 
positive 
emotional state 
1 12 No Continuous 
Response Digital 
Interface (CRDI) - 
happiness 
Mental 
health 
Strehl, 
Kotchoubey, 
Martinetz, 
and 
Birbaumer 
(2011) 
70 Pre-post 
trial 
Non-
USA 
IQ (in 
epilepsy) 
1 30-35 No Wechsler Adult 
Intelligence Scale 
(WAIS) - IQ 
Mental 
health 
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Reference Total 
N 
Design USA 
or 
non-
USA 
EEG 
neurofeedback 
for: 
# of scalp 
training 
electrodes 
# of 
neurofeed
back 
sessions 
QEEG 
used 
Outcome measure(s) Health 
or 
mental 
health 
Surmeli and 
Ertem (2011) 
36 Pre-post 
case series 
Non-
USA 
Obsessive 
Compulsvie 
Disorder 
(OCD) 
≤19 9-84 Yes Yale Brown 
Obsessive-
Compulsive Scale 
(Y-BOCS) 
Mental 
health 
Surmeli and 
Ertem (2010) 
21 Pre-post 
case series 
Non-
USA 
Mental 
retardation 
(DSM-IV) 
≤19 80-160 Yes Wechsler 
Intelligence Scale 
for Children – 
Revised (WISC-R) 
Mental 
health 
Surmeli and 
Ertem (2009) 
13 Pre-post 
case series 
Non-
USA 
Antisocial 
personality 
disorder 
≤19 80-120 Yes Minnesota 
Multiphasic 
Personality 
Inventory (MMPI), 
and Symptom 
Assessment-45 
Questionnaire (SA-
45) 
Mental 
health 
Surmeli, 
Ertem, Eralp, 
and Kos 
(2012) 
51 Pre-post 
case series 
Non-
USA 
Schizophrenia ≤19 58-59 Yes Positive and 
Negative Syndrome 
Scale (PANSS) - 
Total 
Mental 
health 
Surmeli et al. 
(2017) 
40 Prepost 
case series 
Non-
USA 
Postconcussio
n Syndrome 
(PCS) 
≤19 48 Yes Symptom 
Assessment-45 
Questionnaire (SA-
45) and Global 
Severity Index (GSI) 
Mental 
health 
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Reference Total 
N 
Design USA 
or 
non-
USA 
EEG 
neurofeedback 
for: 
# of scalp 
training 
electrodes 
# of 
neurofeed
back 
sessions 
QEEG 
used 
Outcome measure(s) Health 
or 
mental 
health 
Walker 
(2012) 
26 Controlled 
case series 
USA Dysgraphia 1 5-10 Yes Checklist of written 
expression 
Health 
Walker and 
Lawson 
(2013) 
186 Pre-post 
case series 
USA Drug resistant 
depression 
1 6 No Rush quick self-
rated depression 
inventory 
Mental 
health 
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Assessment of Methodological Quality 
To assess for methodological quality, I reviewed each of the studies for 
participation bias, attrition bias, outcome measurement, and data analysis and reporting.  
Participation bias required assessing for an adequate description of the key characteristics 
and inclusion and exclusion criteria applicable to the study population.  Attrition bias 
required assessing for whether the study had a follow-up at least three months after the 
conclusion of the study and documentation of any missing participant data.  Outcome 
measurement required assessing for an objective outcome definition provided in advance 
of the intervention.  Data analysis and reporting domain required assessing for alpha 
(type 1) and/or beta (type 2) error specifications and inclusion of outcome data.  Table 2 
illustrates each criterion and whether or a not a study met that criterion. 
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Table 2  
 
Methodological Quality of Studies Included in Meta-Analysis (N = 21)  
Criteria Criteria met  
 n/N % 
Participation bias   
Adequate description of key characteristics 19/21 90 
Adequate description of inclusion/exclusion criteria 21/21 100 
Attrition bias   
At least 3 months to follow-up 21/21 100 
Documentation of missing participation data  21/21 100 
Outcome measurement   
Objective definition of outcome 21/21 100 
Definition provided in advance of outcome 21/21 100 
Data analysis and reporting   
Alpha and/or beta error specifications 21/21 100 
Outcome data included 21/21 100 
 
Statistical Analyses 
The 21 studies included in the meta-analyses included appropriate data for 
calculating effect sizes.  A single study by Kouijzer et al. (2013) involved two 
independent participant samples, which I have referred to as Kouijzer et al. (2013a) and 
Kouijzer et al. (2013b) in Tables 4 and 6; this increased the overall number of 
comparisons used for the meta-analysis to 22.  Of the 22 comparisons, 12 used an 
intervention and control group and reported pre and post means and standard deviations 
for the intervention and control group.  Nine studies included in the meta-analyses used a 
pre-post within-group design and reported pre and post intervention means and standard 
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deviations.  The remaining study used a pre-post within-group intervention design and 
reported dependent t-test and correlation values.  I used the data in each study to calculate 
an effect size, Cohen’s d, for each of the included outcomes because it is necessary to 
transform data into a common metric when combining results from different study 
designs (Morris & DeShon, 2002; Lipsey & Wilson, 2001).   
The calculated effect size, Cohen’s d, offers a measure of the strength of the 
relationship between variables without making assumptions about the relationship and 
how accurate it reflects the population (Card, 2011).  Each effect size calculation for 
Cohen’s d in this study followed the formula of Lipsey and Wilson (2001) where 
subtracting mean differences of the control or pre-group data (X1) and intervention or 
post-group data (X2) then dividing by the standard deviation (S) equals d: 
𝑑 =
𝑋1 − 𝑋2
𝑆
 
Data entered in CMA (2015) converts all effect sizes to Hedges’ g after 
computing the standardized mean difference.  A benefit of using CMA (2015) appears in 
the ability of the software to accept multiple data formats, convert to Hedges’ g, and run 
the analysis.  Data formats used in CMA (2015) for this meta-analysis include 
“Independent groups (means, SDs)” for the control and intervention post-test scores, 
“Paired groups (mean, SD)” and a pre-post correlation of .99 for the single group pre-post 
test scores, and “change in each group” for the control and intervention change scores. 
The data collected from the 22 study comparisons resulted in Hedges’ g 
calculations for 94 outcomes of interest.  Using multiple outcomes from the same sample 
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would violate the assumption of independence by assigning more weight to the study 
even though the same participants and study are being used more than once in the meta-
analysis (Morris & DeShon, 2002).  To avoid violating this assumption, multiple 
outcomes in the same study with the same population were combined to a single effect 
size using CMA (2015). 
Study Results 
The purpose of this meta-analysis was to evaluate and synthesize the evidence for 
the efficacy of neurofeedback determined by statistical analyses of the results of included 
studies that examined efficacy for physical and mental health outcomes.  Data for each of 
the 94 outcomes was entered into CMA (2015) and after multiple study outcomes were 
combined, 22 outcome statistics were reported as one of the 21 included published 
studies used two independent samples.  CMA (2015) version 3 was used to generate the 
meta-analysis results and included statistics for Hedges’ g and confidence intervals (at 
95%).  Hedges’ g is interpreted similarly as Cohen’s d is interpreted, with a small effect 
at 0.20, a medium effect at 0.50, and a large effect at 0.80 (Lipsey & Wilson, 2001).   
CMA (2015) allowed for the analysis to be completed with random or fixed 
effects models or both.  A fixed effects model assumes that that there is only a single true 
effect size where the random effects model assumes that moderators can create variation 
in the effect size and is more amenable to generalization purposes when considering 
differences in sample sizes of included studies (Borenstein, Hedges, Higgins, & 
Rothstein, 2010).  The random effects model weights small studies and large studies so as 
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to not discount a study with a small sample size or overly credit a study with a large 
sample size, keeping the outcome data in balance when merging a pool of data as is done 
in meta-analysis.  A random effects model was used for this meta-analysis for better 
generalization and because of the varying procedures and measures used across the 
studies included in the meta-analysis.  Effect size estimates completed in CMA (2015) 
were weighted by sample size and sampling error corrections were applied. 
Effect sizes can be overestimated in meta-analysis when considering publication 
bias (Lipsey & Wilson, 2001).  Frequently studies with significant findings are the ones 
published, resulting in publication bias which can artificially increase the knowledge 
base.  CMA (2015) offers the funnel plot as a method to explore publication bias by 
viewing the study size in relation to the effect size; large studies are towards the top, the 
point of the funnel, and smaller studies towards the bottom, the opening of the funnel.  
Symmetrical distribution occurs around the average effect size of each studies effect sizes 
if there is not any evidenced bias.  If publication bias is evidenced, symmetry might 
remain towards the top with studies missing towards the middle and bottom of the plot; 
the missing studies or gaps in the plot are where the insignificant or unpublished studies 
would be found (Borenstein et al., 2010).   
Figure 2 shows the funnel plot for this meta-analysis.  The funnel plot shown in 
figure 2 appears to be a symmetrical inverted funnel, but lacks studies towards the middle 
and bottom of the plot, indicating the probability of publication bias (Lipsey & Wilson, 
2001).  There are three outliers shown in the plot, which represents three studies that 
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varied enough in effect size and standard error to fall outside of the funnel.  The outliers 
are identified in the studies by Prinsloo et al. (2018), Hedges’ g = 4.29, SE = 0.49, 
Kayiran et al. (2010), Hedges’ g = 7.97, SE = 1.00, and Walker (2012), Hedges’ g = 
10.09, SE = 1.57.  It is important to consider that this meta-analysis included a lower 
number of overall studies, 21, with 22 study comparisons, which according to Borenstein 
et al. (2010) might negatively influence the interpretation of the plot; interpretation of 
funnel plots can be subjective. 
Considering the potential subjectivity of funnel plot interpretation, another option 
of inquiry for publication bias in meta-analysis is Classic Fail-Safe N.  According to 
CMA (2015) Classic Fail-Safe N is a calculation of the number of studies missing that 
would be required to be added to the meta-analysis to cancel out the effect, or create 
statistical insignificance (CMA, 2015).  The more studies required to cancel the effect, 
the less likely it is that the true effect is zero or not significant.  For this meta-analysis, 
6,139 studies would be required to cancel the effect.  Of note, the focus of the Classic 
Fail-Safe N is statistical significance and not on substantive significance, which is 
perhaps an archaic approach to determining publication bias in a meta-analysis 
(Borenstein et al., 2010). 
Conducting sensitivity analyses were beneficial to the meta-analysis as they 
offered me an opportunity to view the impact of removing a single study on the overall 
results and average effect size (Morris & DeShon, 2002).  I performed a sensitivity 
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analysis to determine if a study had a greater impact on the average effect size more than 
another study included in this meta-analysis. 
 
Figure 2. Funnel plot for meta-analysis. 
Table 3 depicts the meta-analytic data for study outcomes in this meta-analysis.  
The number of independent samples is represented by k, for this meta-analysis, k = 22 for 
overall studies included, when excluding the outliers, k = 19, the moderator for health 
outcomes, k = 7, and for mental health outcomes, k = 18.  Hedges’ g effect size is 
represented by g, the standard error of Hedges’ g is represented by SEg, the 95% 
confidence interval of Hedges’ g is represented by 95% CI and LL for lower limit and UL 
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for upper limit, the Q statistic is represented by Q, I squared is represented by I2, and tau 
squared is represented by Τ2.   
I included the results for the meta-analysis in Table 3.  For the overall meta-
analysis, g = 0.70, 95% CI = [0.49, 0.92], indicating there is a positive effect of 
neurofeedback on overall outcomes.  After removal of the outliers, g = 0.50, 95% CI = 
[0.27, 0.72], indicating a similar positive effect of neurofeedback on outcomes when the 
outliers are not included in the analysis.  I completed moderator analyses for 
neurofeedback for physical and mental health outcomes.  Neurofeedback for physical 
health resulted in a positive effect, g = 0.81, 95% CI = [0.54, 1.08] and neurofeedback for 
mental health resulted in a positive effect, g = 0.59, 95% CI = [0.34, 0.82].  The 
confidence intervals for neurofeedback for physical and mental health moderators 
overlapped between the two outcomes, suggesting that the effect of neurofeedback did 
not differ between physical or mental health outcomes. 
Data describing heterogeneity is in Table 3.  Heterogeneity was assessed with the 
Q Statistic.  The Q statistic depicts the presence or absence of heterogeneity, or whether 
the included studies are homogeneous (Card, 2011).  I2 expresses the degree of 
heterogeneity as a percent of variance due to heterogeneity rather than variance due to 
chance (CMA, 2015).  The overall meta-analysis resulted in I2 = 99.9%, with outliers 
excluded I2  = 99.9%, for physical health outcomes I2  = 97.9, and for mental health 
outcomes I2  = 99.9%.  The high I2  statistic indicates that variance within this meta-
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analysis has occurred with a normal distribution between studies.  Τ2 is a measure of 
variance of the effect sizes between the included studies.  
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Table 3  
 
Meta-analysis for Study Outcomes 
    95% CI    
 K g SEg LL UL Q I
2 (%) T2 
Overall 22 0.70 0.11 0.49 0.92 24653.19** 99.9% .18 
Overall (excluding outliers) 19 0.50 0.12 0.27 0.72 24470.98** 99.9% .19 
Health Outcomes 7 0.81 0.14 0.54 1.08 281.74** 97.9% .06 
Mental Health Outcomes 18 0.59 0.12 0.34 0.82 24422.85 99.9% .20 
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Research Question 
What are the effects of neurofeedback on physical and mental health outcomes 
across published and unpublished studies? 
 The hypothesis was that neurofeedback has a significant effect on physical and 
mental health outcomes across published and unpublished studies.  The null hypothesis 
was that neurofeedback does not have a significant effect on physical and mental health 
outcomes as determined by a meta-analysis of published and unpublished studies. 
 After running the meta-analysis for the 22 included study comparisons the overall 
effect size, Hedges’ g was moderately significant, g = 0.70, 95% CI = [0.49, 0.92].  Table 
4 displays the effect sizes for each of 22 comparisons.  After removing the outliers and 
running the meta-analysis for the 19 studies effect size, Hedges’ g was moderately 
significant, g = 0.50, 95% CI = [0.27, 0.72].  These findings permit the rejection of the 
null hypothesis and confirm the hypothesis that neurofeedback has a significant effect on 
physical and mental health outcomes across published and unpublished studies. 
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Table 4 
 
Overall Hedges’ g 
Study Variable Hedges’ g SEg 
Imperatori et al. (2017) Combined 0.11 0.28 
Hong, and  Lee (2012) Combined 0.73 0.52 
Kouijzer et al.(2010) Combined 1.22 0.48 
Dalkner et al. (2017) Combined 0.23 0.39 
Prinsloo et al. (2018) Combined 4.29 0.49 
Saki et al. (2016) Combined 0.77 0.60 
Kayiran et al. (2010) Combined 7.97 1.00 
Walker (2012) Dysgraphia 10.09 1.57 
Kouijzer et al. (2013)a Combined -0.06 0.46 
Kouijzer et al. (2013)b Combined -0.29 0.49 
Sokhadze and Daniels (2016) Happiness 0.66 0.31 
Strehl et al. (2011) IQ 0.10 0.01 
Jensen et al. (2013) Pain 0.30 0.01 
Crocetti et al. (2011) Tinnitus 0.10 0.01 
Surmeli and Ertem (2010) Intelligence 0.23 0.01 
Surmeli and Ertem (2009) Combined 0.20 0.01 
Surmeli et al. (2017) Post-concussion Symptoms 1.51 0.01 
Surmeli el a. (2012) Schizophrenia 0.76 0.01 
Surmeli and Ertem (2011) Obsessive Compulsive 
Disorder 
1.12 0.01 
Walker and Lawson (2013) Depression 0.28 0.00 
Hammer et al. (2011) Insomnia 0.52 0.02 
Chirita-Emandi and Puiu (2014) Combined 0.40 0.36 
 
 Separating the effects of neurofeedback on physical and mental health outcomes 
across published and unpublished studies was not specifically part of the research 
question, but was used in moderator analyses to provide additional data for this meta-
analysis.  The additional data using moderator analyses for physical and mental health 
might have offered insight into whether or not neurofeedback had efficacy for physical or 
mental health outcomes rather than physical and mental health outcomes.  Table 5 
displays the effect sizes for each of the included health outcomes.  After I conducted the 
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analysis using health outcomes as the moderator, the seven studies’ effect size was g = 
0.81, 95% CI = [0.54, 1.08] indicating a large effect; a positive effect for the use of 
neurofeedback for health outcomes.  Table 6 displays each of the included effect sizes for 
the mental health outcomes.  The moderator analysis for mental health outcomes of 18 
studies resulted in an effect of g = 0.59, 95% CI = [0.34, 0.82], a medium effect; also 
indicating a positive effect of neurofeedback for mental health outcomes.  A closer look 
at the confidence intervals indicated overlap among physical and mental health outcomes, 
suggesting that the effect of neurofeedback did not differ based on outcome type. 
Table 5 
 
Health Outcomes Hedges’ g 
Study Variable Hedges’ g SEg 
Imperatori et al. (2017) Food cravings 0.05 0.28 
Prinsloo et al. (2018) Combined 4.29 0.49 
Kayiran et al. (2010) Combined 7.69 0.96 
Walker (2012) Dysgraphia 10.09 1.57 
Jensen et al. (2013) Pain 0.30 0.01 
Hammer et al. (2011) Insomnia 0.52 0.02 
Chirita-Emandi and Puiu (2014) Combined 0.37 0.35 
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Table 6 
 
Mental Health Outcomes Hedges’ g 
Study Variable Hedges’ g SEg 
Imperatori et al. (2017) Overall psychological 
distress 
0.18 0.28 
Hong, and  Lee (2012) Combined 0.73 0.52 
Kouijzer et al.(2010) Combined 1.22 0.48 
Dalkner et al. (2017) Combined 0.23 0.39 
Saki et al. (2016) Combined 0.77 0.60 
Kayiran et al. (2010) Combined 8.12 1.01 
Kouijzer et al. (2013)a Combined -0.06 0.46 
Kouijzer et al. (2013)b Combined -0.29 0.49 
Sokhadze and Daniels (2016) Happiness 0.66 0.31 
Strehl et al. (2011) IQ 0.10 0.01 
Crocetti et al. (2011) Tinnitus 0.10 0.01 
Surmeli and Ertem (2010) Intelligence 0.23 0.01 
Surmeli and Ertem (2009) Combined 0.20 0.01 
Surmeli et al. (2017) Post-concussion Symptoms 1.51 0.01 
Surmeli el a. (2012) Schizophrenia 0.76 0.01 
Surmeli and Ertem (2011) Obsessive Compulsive 
Disorder 
1.12 0.01 
Walker and Lawson (2013) Depression 0.28 0.00 
Chirita-Emandi and Puiu (2014) Combined 0.42 0.36 
 
Summary 
The results of the meta-analysis were reported in this chapter, including how the 
collected data answered the research question.  Overall there is a positive effect for 
neurofeedback on physical and mental health outcomes.  The positive effect remains 
evident when the outliers are removed and when the data is moderated by physical or 
mental health outcomes separately.  The included funnel plot addressed possible 
publication bias through visual inspection of the location of the studies within the funnel 
and identified three outliers that were studies with enough variation in effect size to fall 
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outside of the funnel.  The funnel plot for this meta-analysis indicates the probability of 
publication bias, a lack of studies with unfavorable outcomes being published.  The 
systematic review for this meta-analysis resulted in 1,879 records and after further 
review, 21 published research articles were included with a single article having two 
independent study samples resulting in the inclusion of 22 study comparisons in the 
meta-analysis.  The meta-analysis results depict efficacy for neurofeedback for health and 
mental health outcomes.  The efficacy of the treatment remains evident after the three 
outlier studies are removed.  Chapter 5 includes a summary and interpretation of the 
results, limitations, and directions for future research.  
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Chapter 5: Discussion, Conclusions, and Recommendations 
Symptoms of diminished daily functioning such as those experienced in physical 
or mental health diagnoses are potentially uncomfortable, unpleasant, and difficult to 
overcome.  Most clinical treatment modalities meant to improve physical or mental 
health, including neurofeedback, have the potential for side effects (Hammond & Kirk, 
2015).  Without clear knowledge regarding the efficacy of neurofeedback, it might not 
makes sense for an individual to undergo the treatment and risk the potential side effects 
or placebo effects.  According to King (2016), psychologists regularly examine available 
evidence to provide valuable insight about the data and how it relates to human existence.  
Thus, in addition to demonstrating mastery of meta-analysis research protocols, this 
systematic review and meta-analysis of the efficacy of neurofeedback has pedagogic 
value for understanding the body of evidence on neurofeedback for physical health and 
mental health outcomes.   
Summary of the Findings 
After a systematic review of 1,879 records connected to neurofeedback, I 
included 21 studies in the meta-analysis and statistically analyzed 22 study comparisons 
after including the two independent samples from a single study. I determined that 
neurofeedback has a significant positive effect on physical and mental health outcomes.  
When outliers from three articles were removed from the analysis, the significant effect 
of neurofeedback treatment remained.  After moderating the data for physical health 
outcomes and again for mental health outcomes, significant results remained.  This is 
indicative of efficacy of neurofeedback for physical and mental health outcomes, yet 
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caution should still be exercised when considering neurofeedback as a treatment option 
due to evidence of probable publication bias.  It remains possible that neurofeedback 
studies reporting inefficacy have not been published. 
Interpretation of Findings 
Skinner’s (1938) theory of operant conditioning holds that delivery of positive 
and negative consequences directly following behavior can change future behavior.  This 
theory appears applicable to neurofeedback.  The positive results of this meta-analysis 
agree with Kobayashi et al. (2010) who found that in the theory of operant conditioning 
there is a connection between brain waves and behavior that is exploited in a functional 
way with neurofeedback to create brain wave and behavior change.   
In this meta-analysis, I determined that using neurofeedback treatment distinguish 
and healthy from unhealthy brain functioning and, by extension, healthy from unhealthy 
daily levels of functioning increased physical and mental health outcomes.  When 
separating the physical from mental health outcomes, I included more mental health 
outcomes (18) than physical health outcomes (seven) in this meta-analysis.  After 
conducting moderator analysis using physical health outcomes and then mental health 
outcomes as moderators, I found that both showed a positive effect of neurofeedback.  It 
is important to note that the confidence intervals for the moderator analysis of physical 
and mental health outcomes indicated overlap among these outcomes suggesting that the 
effect of neurofeedback did not differ based on outcome type.  Studies were not excluded 
if they did not have a placebo or control condition, overcoming the argument by 
Thompson and Thompson (2016) that dismissing studies without a placebo or control 
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condition might overlook a significant portion of the available clinical research and not 
contribute to an increased understanding of the efficacy of neurofeedback. 
Cumming (2013) discussed meta-analysis as a systematic method for combining 
multiple studies to determine effects that are practical and usable for researchers and 
clinicians.  Adding teachers or future teachers to the discussion is valuable for meta-
analytic research, the knowledge base, and education as the process of active engagement 
in the method and the determination of efficacy for a body of evidence.  Meta-analytic 
experience has value for increasing effectiveness of instruction and for offering a much 
needed analysis of the state of an art, such as neurofeedback (Horn et al., 2014; 
Thompson & Thompson, 2016). 
Limitations of the Study 
A limitation to this meta-analysis was a lack of available research on the use of 
neurofeedback for physical and mental health outcomes that included more than 100 
participants.  The majority of the studies included in this meta-analysis had small sample 
sizes with up to 51 participants.  According to Creswell (2014), researchers should select 
a sample size large enough to reflect the population from which it is drawn with the 
alterative option being the use of a power analysis to compare populations or groups.  
Cuijpers and Cristea (2016) noted that researchers demonstrating an effect in test subjects 
without quantifying the population is likely to result in positive outcomes and research 
that is difficult to compare to other research involving significantly larger numbers of 
subjects. 
77 
 
 
I restricted data in this meta-analysis to those from studies published in English.  
The possibility remains that searching in a different language or searching scientific 
databases in different languages could result in an increase in the number of available 
studies for inclusion in a similar meta-analysis.   
My goal in this meta-analysis was to determine the effects of neurofeedback on 
physical health and mental health outcomes, not physical health or mental health 
outcomes.  I used moderator analyses to determine if, after separation of the included 22 
comparisons by physical health outcome or mental health outcome, either physical or 
mental health were not suited for treatment via neurofeedback.  Of note is that after 
separation of the included comparisons, this meta-analysis included more mental health 
outcomes (18) than physical health outcomes (seven).  If neurofeedback is better suited 
for mental health outcomes or health outcomes, then the use of the treatment becomes 
limited and can be better focused on the outcome it is better suited to treat. 
The number of studies excluded for not having a follow up study at least three 
months following the completion of the study is limiting to determining long term 
efficacy of a treatment.  Retention of learned skill, as in neurofeedback, is important to 
the practical application of the treatment for practitioners and consumers.  If the reported 
positive effects of neurofeedback were not sustainable and did not last, the use of the 
treatment becomes limited as it would need to be repeated to maintain the same or similar 
results.   
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Recommendations 
Prior to the publication of new research, future meta-analytic investigations to 
determine the effect of neurofeedback on physical and mental health outcomes could 
include studies published in languages other than English.  It is possible that searching 
databases not in English and obtaining research not written in English could add to the 
number of studies available for inclusion in the meta-analysis.  Future meta-analysis 
might include neurofeedback with combined interventions and compare the effects of 
neurofeedback as a stand-alone treatment and the effects when combined with other 
treatments.  Another option for future meta-analyses is to include studies with under a 
three-month follow up and compare outcomes or retention of learned skills between those 
with and without a three-month follow up.   
None of the included research studies had physical or mental health specifically 
identified as the outcome being investigated.  While the outcomes were fitting for 
categorization as physical or mental health outcomes, future researchers investigating 
neurofeedback could focus specifically on physical or mental health as the outcomes of 
interest rather than on things like depression or tinnitus.  A whole-body approach might 
increase the understanding of the treatment and application. 
Implications for Social Change 
According to the World Health Organization (2018) physical and mental health 
are more complicated than simply the absence of disease and are fundamental to safety 
and peace within societies and communities.  The World Health Organization (2014) 
noted that physical health and mental health are states of physical, emotional, and social 
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well-being that could be evidenced by an ability to handle normal life stress, work, and 
contribution to society.  The potential for positive social change through the use of 
neurofeedback treatment for physical and mental health is simple; increased physical and 
mental health increases safety and peace in societies and communities.  For the 
individual, increased physical and mental health increase one’s ability to handle normal 
life and work stress and contribute to society. 
In this meta-analysis, I achieved mastery learning through the active construction 
of knowledge.  Mastery learning increases the quality and effectiveness of future 
instruction and learning (Ouyang & Stanley, 2014; Horn et al., 2014).  Increased quality 
of instruction can increase the quality of learning for students, and an increase to both can 
positively impact social change in individuals and communities through increased 
education and potential action of the members of communities and families.   
Conclusions 
In this meta-analysis I sought to understand the efficacy of neurofeedback for 
physical and mental health outcomes while simultaneously acquiring pedagogic value in 
conducting meta-analytic research.  I increased my understanding of the state of the art of 
neurofeedback for physical and mental health outcomes in this meta-analysis, because it 
indicated a significant and positive effect on physical and mental health outcomes.  The 
number of included research articles was limited (21), as was the number of included 
study comparisons for analysis (22), yet it was still possible to interpret the overall results 
of the meta-analysis that neurofeedback has efficacy for improving physical and mental 
health.  The findings support the theory of operant conditioning and the ability of 
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neurofeedback to utilize the theory to create improvement to physical and mental health 
for those who undergo a series of neurofeedback treatment training sessions.  
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